臨床研究センター

2026年7月8日掲載

2024年度英文論文

• 1. A Yanagisawa, T Takimoto, Y Kurahara, K Tsuyuguchi, S Yoshida, M Hirose, Y Inoue, T Arai A Case of  Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy Internal Medicine 2023 Nov;63(14):2043-2047.(柳澤篤)
• 2. Okuma Y,Kubota K,Shimokawa M,Hashimoto K,Kawashima Y,Sakamoto T,Wakui H,Murakami S,Okishio K,Hayashihara K,Ohe Y First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations The UNICORN Phase 2 Nonrandomized Clinical Trial JAMA Oncology 2024 Jan;10(1):43-51.(沖塩協一)
• 3. Tomioka H,Miyazaki Y,Inoue Y,Egashira R,Kawamura T,Sano H,Johkoh T,Takemura T,Hisada T,Fukuoka J,Comm Japanese Resp Soc Japane Japanese clinical practice guide 2022 for hypersensitivity pneumonitis Respiratory investigation 2024 Jan;62(1):16-43.(井上義一)
• 4. Tamiya A Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors Respiratory investigation 2024 Jan;62(1):85-89.(田宮朗裕)
• 5. Nishio M,Murakami S,Kawakami H,Okishio K,Tamiya M,Kobayashi H,Fujimoto D,Sugawara S,Kozuki T,Oya Y,Izumi H,Shiroyama T,Satouchi M,Yamamoto N,Kaname S,Matsuoka D,Otake Y,Takase T,Semba T,Azuma K Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort Cancer Research Communications 2024 Jan;4(1):226-235.(沖塩協一)
• 6. Matsumoto K,Shiroyama T,Tamiya M,Minami T,Kinehara Y,Tamiya A,Suga Y,Kuge T,Mori M,Suzuki H,Tobita S,Ueno K,Namba Y,Tetsumoto S,Niki T,Morimura O,Osa A,Nishino K,Nagatomo I,Takeda Y,Kijima T,Kumanogoh A Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study Cancer Immunology Immunotherapy 2024 Jan;73(1):(田宮朗裕)
• 7. Kobayashi T,Tsuyuguchi K,Shimatani Y,Matsuda Y,Kagawa T,Takimoto T,Takeuchi N,Arai T,Inoue Y Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis Journal of Infection and Chemotherapy 2024 Jan;30(1):7-11.(小林岳彦)
• 8. Walsh SLF, De Backer J, Prosch H, Langs G, Calandriello L, Cottin V, Brown KK, Inoue Y, Tzilas V, Estes E; Open Source Imaging Consortium (OSIC). Towards the adoption of quantitative computed tomography in the management of interstitial lung disease European Respiratory Review 2024 Jan 31;33(171):230055.(井上義一)
• 9. Shibaki R,Fujimoto D,Nozawa T,Sano A,Kitamura Y,Fukuoka J,Sato Y,Kijima T,Matsumoto H,Yokoyama T,Miura S,Hata A,Tamiya M,Taniguchi Y,Sugisaka J,Furuya N,Tanaka H,Yamamoto N,Koh Y,Akamatsu H Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER 2024 Feb;12(2):(谷口善彦)
• 10. Mitsudomi T,Ito H,Okada M,Sugawara S,Shio Y,Tomii K,Okami J,Sakakura N,Kubota K,Takamochi K,Atagi S,Tsuboi M,Oizumi S,Ikeda N,Ohde Y,Ntambwe I,Mahmood J,Cai JL,Tanaka F Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816 Cancer Science 2024 Feb;115(2):540-554.(安宅信二)
• 11. Ikeda S,Tsuboi M,Sakai K,Misumi T,Akamatsu H,Shoda H,Sakakura N,Nakamura A,Ohde Y,Hayashi H,Okishio K,Okada M,Yoshino I,Okami J,Takahashi K,Ikeda N,Tanahashi M,Tambo Y,Saito H,Toyooka S,Inokawa H,Chen-Yoshikawa T,Yokoyama T,Okamoto T,Yanagitani N,Oki M,Takahama M,Sawa K,Tada H,Nakagawa K,Mitsudomi T,Nishio K NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study Molecular Oncology 2024 Feb;18(2):305-316.(沖塩協一)
• 12. Kagawa T,Kurahashi K,Seki T,Kawasaki Y,Nahara I,Takeda C,Yonekura H,Tanaka S,Kawakami K The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database Journal of Anesthesia 2024 Feb;38(1):92-97.(香川智子)
• 13. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Taniguchi Y,Nosaki K,Fukumitsu K,Akechi T Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer Oncologist 2024 Feb 2;29(2):e282-e289.(松田能宣)
• 14. Akira M,Suganuma N Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia Canadian Respiratory Journal 2024 Feb 14;2024(審良正則)
• 15. Kurahara Y,Okamori H,Tsuyuguchi K A Large Cavity Associated with Pulmonary Infarction Internal medicine 2024 Mar;63(20):2867-2868.(倉原優)
• 16. Morimoto K,Nonaka M,Yamazaki Y,Nakagawa T,Takasaki J,Tsuyuguchi K,Kitada S,Jumadilova Z,Yuen DW,Ciesielska M,Hasegawa N Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study Respiratory investigation 2024 Mar;62(2):284-290.(露口一成)
• 17. Molina TJ,Roden AC,Szolkowska M,Shimizu S,Moreira AL,Chalabreysse L,Besse B,de Montpr V,Marom EM,Detterback F,Girard N,Nicholson AG,Marx A International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study Lung Cancer 2024 Mar;189(清水重喜)
• 18. Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry. JACC-ASIA 2024 Mar;4(5):403-417.(井上義一)
• 19. Isobe K,Nakamura Y,Sakamoto S,Tomii K,Takimoto T,Miyazaki Y,Matsumoto M,Sugino K,Ichikado K,Moriguchi S,Yamaguchi K,Baba T,Ozasa H,Igata F,Anabuki K,Homma S,Date H,Suda T,Kishi K Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia ERJ Open Research 2024 Mar 1;10(2):(滝本宜之)
• 20. Richeldi L,Schiffman C,Behr J,Inoue Y,Corte TJ,Cottin V,Jenkins RG,Nathan SD,Raghu G,Walsh SLF,Jayia PK,Kamath N,Martinez FJ Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial American Journal of Respiratory and Critical Care Medicine 2024 May 1;209(9):1132-1140.(井上義一)
• 21. Wada T,Yoshida S,Yamamoto T,Nonaka L,Fukushima Y,Nakajima C,Suzuki Y,Imajoh M Application of Genomic Epidemiology of Pathogens to Farmed Yellowtail Fish Mycobacteriosis in Kyushu, Japan Microbes and Environments 2024;39(2):ME24011.(𠮷田志緒美)
• 22. Amano K,Baracos VE,Mori N,Okamura S,Yamada T,Miura T,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer Clinical Nutrition ESPEN 2024 Apr;60313-319.(松田能宣)
• 23. Enomoto N,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Aono Y,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Sano T,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Nakamura Y,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study Respiratory Medicine 2024 Apr;224(澄川裕充)
• 24. Kanemura H,Yokoyama T,Nakajima R,Nakamura A,Kuroda H,Kitamura Y,Shoda H,Mamesaya N,Miyata Y,Okamoto T,Okishio K,Oki M,Sakairi Y,Chen-Yoshikawa TF,Aoki T,Ohira T,Matsumoto I,Ueno K,Miyazaki T,Matsuguma H,Yokouchi H,Otani T,Ito A,Sakai K,Chiba Y,Nishio K,Yamamoto N,Okamoto I,Nakagawa K,Takeda M The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma JTO CLINICAL AND RESEARCH REPORTS 2024 Apr;5(4):(沖塩協一)
• 25. Kako J,Kajiwara K,Kobayashi M,Kanno Y,Morikawa M,Nakano K,Matsuda Y,Shimizu Y,Niino M,Suzuki M,Shimazu T Applicability of Nursing Support for Patients With Terminal Cancer and Their Families: A Delphi Study AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE 2024 Apr 5;42(2):145-154.(松田能宣)
• 26. Hasegawa T,Mori M,Yamaguchi T,Imai K,Matsuda Y,Maeda I,Hatano Y,Yokomichi N,Hamano J,Morita T Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study Journal of Palliative Medicine 2024 Dec 5;(松田能宣)
• 27. Shimaya M,Inagaki Y,Arai T,Kawakami M,Takeuchi N,Sumikawa H,Shimizu S,Takimoto T,Inoue Y Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome Internal medicine 2024 May;63(10):1451-1457.(島矢未奈子)
• 28. Taniguchi Y,Arai T,Tsuji T,Sugimoto C,Tachibana K,Akira M,Inoue Y Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases Journal of Thoracic Disease 2024 May;16(5):3129-+.(谷口善彦)
• 29. Hoshida Y,Tsujii A,Ohshima S,Saeki Y,Yagita M,Miyamura T,Katayama M,Kawasaki T,Hiramatsu Y,Oshima H,Murayama T,Higa S,Kuraoka K,Hirano F,Ichikawa K,Kurosawa M,Suzuki H,Chiba N,Sugiyama T,Minami Y,Niino H,Ihata A,Saito I,Mitsuo A,Maejima T,Kawashima A,Tsutani H,Takahi K,Kasai T,Shinno Y,Tachiyama Y,Teramoto N,Taguchi K,Naito S,Yoshizawa S,Ito M,Suenaga Y,Mori S,Nagakura S,Yoshikawa N,Nomoto M,Ueda A,Nagaoka S,Tsuura Y,Setoguchi K,Sugii S,Abe A,Sugaya T,Sugahara H,Fujita S,Kunugiza Y,Iizuka N,Yoshihara R,Yabe H,Fujisaki T,Morii E,Takeshita M,Sato M,Saito K,Matsui K,Tomita Y,Furukawa H,Tohma S Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders Arthritis & rheumatology 2024 Jun 10;76(6):869-881.(笠井孝彦)
• 30. Kurahara Y,Shimatani Y Laryngitis Caused by Mycobacterium abscessus Subspecies massiliense Infection JMA Journal 2024 Jul 16;7(3):441-442.(倉原優)
• 31. Amano K,Okamura S,Matsuda Y,Baracos VE,Mori N,Miura T,Tatara R,Kessoku T,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with depression in patients with advanced cancer Supportive Care in Cancer 2024 Jul;32(7):(松田能宣)
• 32. Sakurai T,Kanou T,Funaki S,Fukui E,Kimura T,Ose N,Inoue Y,Shintani Y Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study Respiratory investigation 2024 Jul;62(4):657-662.(井上義一)
• 33. Inoue Y,Kitamura H,Okamoto M,Ogura T,Nishioka Y,Kuwana M,Taniguchi A,Ito T,Rohr KB,Suda T The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial Respiratory investigation 2024 Jul;62(4):589-596.(井上義一)
• 34. Tsuboi M,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Tokito T,Mio T,Adachi H,Kozuki T,Sone T,Seike M,Toyooka S,Kitagawa H,Koto R,Yamazaki S,Horinouchi H Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study Thoracic cancer 2024 Jul;15(20):1541-1552.(安宅信二)
• 35. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Inagaki Y,Nosaki K,Fukumitsu K,Akechi T Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer Supportive Care in Cancer 2024 Jul;32(7):(稲垣雄士)
• 36. Miwa S,Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigators Potential Efficacy of Midazolam as Second-Line Treatment for Terminal Dyspnea in Patients with Cancer: Secondary Analysis of a Multicenter Prospective Cohort Study Palliative Medicine Reports 2024 Jul 1;5(1):225-233.(松田能宣)
• 37. Kojima K,Samejima H,Iguchi T,Tokunaga T,Okishio K,Yoon H Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer Scientific reports 2024 Jul 4;14(1):(小島健介)
• 38. Enomoto T,Shirai Y,Takeda Y,Edahiro R,Shichino S,Nakayama M,Takahashi-Itoh M,Noda Y,Adachi Y,Kawasaki T,Koba T,Futami Y,Yaga M,Hosono Y,Yoshimura H,Amiya S,Hara R,Yamamoto M,Nakatsubo D,Suga Y,Naito M,Masuhiro K,Hirata H,Iwahori K,Nagatomo I,Miyake K,Koyama S,Fukushima K,Shiroyama T,Naito Y,Futami S,Natsume-Kitatani Y,Nojima S,Yanagawa M,Shintani Y,Nogami-Itoh M,Mizuguchi K,Adachi J,Tomonaga T,Inoue Y,Kumanogoh A SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis Takatoshi Enomoto, ... , Yoshikazu Inoue, Atsushi Kumanogoh JCI Insight 2024 Jul 10;9(11):(井上義一)
• 39. Nakano K,Kanno Y,Kajiwara K,Kobayashi M,Morikawa M,Matsuda Y,Shimizu Y,Shimazu T,Kako J Nursing Support for Constipation in Patients with Cancer: A Scoping Review Journal of Palliative Medicine 2024 Jul 29;28(1):115-122.(松田能宣)
• 40. Kurahara Y,Tanaka Y,Kobayashi T,Yoshida S,Tsuyuguchi K Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease Journal of Infection and Chemotherapy 2024 Aug;30(8):780-784.(倉原優)
• 41. Hamamoto Y,Kawamura M,Uchida H,Hiramatsu K,Katori C,Asai H,Shimizu S,Egawa S,Yoshida K The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model International Journal of Surgical Pathology 2024 Aug;32(5):890-894.(清水重喜)
• 42. Shimizu M,Maeda I,Kessoku T,Ishiki H,Matsuura T,Hiratsuka Y,Matsuda Y,Hasegawa T,Imai K,Oyamada S,Satomi E The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study Supportive Care in Cancer 2024 Aug;32(8):(松田能宣)
• 43. Yaga M,Hasegawa K,Ikeda S,Matsubara M,Hiroshima T,Kimura T,Shirai Y,Tansri W,Uehara H,Tachikawa M,Okairi Y,Sone M,Mori H,Kogue Y,Akamine H,Okuzaki D,Kawagishi K,Kawanaka S,Yamato H,Takeuchi Y,Okura E,Kanzaki R,Okami J,Nakamichi I,Nakane S,Kobayashi A,Iwazawa T,Tokunaga T,Yokouchi H,Yano Y,Uchida J,Mori M,Komuta K,Tachi T,Kuroda H,Kijima N,Kishima H,Ichii M,Futami S,Naito Y,Shiroyama T,Miyake K,Koyama S,Hirata H,Takeda Y,Funaki S,Shintani Y,Kumanogoh A,Hosen N CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy Scientific reports 2024 Aug 2;14(1):(德永俊照)
• 44. Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status BMC Pulmonary Medicine 2024 Aug 24;24(24):407.(谷口善彦)
• 45. Takimoto T, Sumikawa H, Inoue Y, Arai T. Auto-Fluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Auto-Fluorescence Sign. American Journal of Respiratory and Critical Care Medicine 2024 Sep;210(5):665-668.(滝本宜之)
• 46. Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K. Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy Thoracic Cancer 2024 Sep;15(26):1882-1888.(露口一成)
• 47. Tanaka Y,Kobayashi T,Shimizu S,Kurahara Y Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug Internal medicine 2024 Sep;63(18):2587-2588.(田中悠也)
• 48. Ueno M,Egashira R,Hashisako M,Fujimoto K,Fukuda T,Hayashida Y,Sumikawa H,Tominaga J,Tanaka T,Terasaki Y,Fukuoka J,Nishioka Y,Aoki T,Gabata T,Hatabu H,Johkoh T Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence Japanese Journal of Radiology 2024 Sep;42(9):993-1002.(澄川裕充)
• 49. Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung Cancer 2024 Sep;195107917.(田宮朗裕)
• 50. Moda M,Sumikawa H,Shintani R,Takeuchi N,Kagawa T,Takimoto T,Arai T Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease Respiratory investigation 2024 Sep;62(5):872-878.(茂田光弘)
• 51. Matsumoto K,Yamamoto Y,Shiroyama T,Kuge T,Mori M,Tamiya M,Kinehara Y,Tamiya A,Suzuki H,Tobita S,Ueno K,Niki T,Nagatomo I,Takeda Y,Kumanogoh A Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study Targeted Oncology 2024 Sep;19(5):757-767.(田宮朗裕)
• 52. Takimoto T,Sumikawa H,Inoue Y,Arai T Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome Negative Autofluorescence Sign American Journal of Respiratory and Critical Care Medicine 2024 Sep 1;210(5):665-668.(滝本宜之)
• 53. Enomoto N,Nakai S,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Fujii M,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Nakamura Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study Respiratory Research 2024 Sep 28;25(1):(澄川裕充)
• 54. Kojima K,Samejima H,Okishio K,Tokunaga T,Yoon H,Atagi S Impact of the number of dissected lymph nodes on machine learning-based prediction of postoperative lung cancer recurrence: a single-hospital retrospective cohort study BMJ Open Respiratory Research 2024 Sep 28;11(1):(小島健介)
• 55. Kubo K,Sakuraya M,Sugimoto H,Takahashi N,Kano K,Yoshimura J,Egi M,Kondo Y Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis Critical Care Medicine 2024 Oct;52(10):e522-e534.(杉本裕史)
• 56. Shibaki R,Fujimoto D,Miyauchi E,Tsukita Y,Nakachi I,Arai D,Sakata Y,Shingu N,Shimokawa T,Kijima T,Tamiya M,Kawana S,Harai S,Saito G,Sato Y,Yokoyama T,Sakata S,Taniguchi Y,Hata A,Matsumoto H,Yamaguchi T,Yamamoto N Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial Lung Cancer 2024 Oct;196(谷口善彦)
• 57. Tsukaguchi A,Tamiya A,Fukuda S,Iwahashi Y,Kanaoka K,Tanaka Y,Inagaki Y,Taniguchi Y,Nakao K,Kagawa T,Matsuda Y,Okishio K Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer Anticancer Research 2024 Oct;44(10):4517-4524.(塚口晃洋)
• 58. Sumikawa H,Johkoh T,Egashira R,Sugiura H,Sugimoto C,Tanaka T,Nakamura M,Kuriu A,Tomiyama N,Fujisawa T,Nakamura Y,Suda T Variability of radiological and clinical features in cases with usual interstitial pneumonia without honeycombing European Journal of Radiology 2024 Oct;179(澄川裕充)
• 59. Wijsenbeek MS,Swigris JJ,Spagnolo P,Kolb M,Kreuter M,Nunes H,Stansen W,Rohr KB,Inoue Y,INBUILD Trial Investigators Worsening dyspnoea as a predictor of progression of pulmonary fibrosis European Respiratory Journal 2024 Oct;64(4):(井上義一)
• 60. Kako J,Morikawa M,Kajiwara K,Kobayashi M,Kanno Y,Nakano K,Matsuda Y Nursing Practices for Dyspnea Management in Patients with Cancer Based on Monthly and Weekly Prognoses: A Multi-Site Cross-Sectional Study of Palliative Care Nurses in Japan Palliative Medicine Reports 2024 Oct 1;5(1):440-444.(松田能宣)
• 61. Yamaguchi T,Matsuda Y,Watanabe H,Kako J,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,JSPM Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine Journal of Palliative Medicine 2024 Oct 1;27(10):1404-1414.(松田能宣)
• 62. Kajiwara K,Kobayashi M,Nakano K,Kanno Y,Morikawa M,Matsuda Y,Kako J Use of Nursing Support Among Nurses for Caregiver Burden in Family Caregivers of Terminally Ill Patients with Cancer in Palliative Care Units in Japan: Multisite Cross-Sectional Study Palliative Medicine Reports 2024 Oct 1;5(1):425-429.(松田能宣)
• 63. Sakura K,Kuroyama M,Shintani Y,Funaki S,Atagi S,Kadota Y,Kuribayashi K,Kijima T,Nakano T,Nakajima T,Sasai M,Okumura M,Kaneda Y Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial Cancer Immunology Immunotherapy 2024 Oct 3;73(12):(安宅信二)
• 64. Hasuo H,Ishiki H,Matsuda Y,Matsuoka H,Kosugi K,Xing M,Akiyama Y,Matsumoto Y,Ishikawa H Trigger point injections for myofascial pain in terminal cancer: a randomized trial Pain Medicine 2024 Oct 12;26(1):14-21.(松田能宣)
• 65. Kondoh Y,Furukawa T,Hozumi H,Suda T,Egashira R,Jokoh T,Fukuoka J,Kuwana M,Teramachi R,Fujisawa T,Hasegawa Y,Ogura T,Miyazaki Y,Oyama S,Teramukai S,Horiguchi G,Naito A,Inoue Y,Ichikado K,Bando M,Tomioka H,Nishioka Y,Chiba H,Ebina M,Nakanishi Y,Satoh K,Shiratori Y,Hashimoto N,Ishii M The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis BMC pulmonary medicine 2024 Oct 14;24(1):(井上義一)
• 66. Drent M, Russell AM, Saketkoo LA, Spagnolo P, Veltkamp M, Wells AU; representatives of the sarcoidosis community: Nicole Goh, Anne Holland, Johann Hochreiter, Selene Kock, Karolien Verheyen, Johan Verbraecken, André Cantin, Ashley Gillson, Nathan Hambly, Martin Kolb, Elisabeth Bendstrup, Anna Leistiko, Janne Møller, Riitta Kaarteenaho, Bruno Crestani, Dominique Israël-Biet, Fleur Cohen Aubart, Hilario Nunes, Dominique Valeyre, Francesco Bonella, Katharina Buschulte, Ulrich Costabel, Peter Kortsen, Michael Kreuter, Peter Luedike, Bernd Quadder, Renate Braune, Dirk Skowasch, Katerina Antoniou, Demosthenes Bouros, Athena Gogali, George A Margaritopoulos, Despoina Papakosta, Spyros A Papiris, Effrosyni D Manali, Argyris Tzouvelekis, Vasilios Tzilas, Aditya Agrawal, Surender Kashyap, Vijay Narain Tyagi, Desai Unnati, Atefeh Abedini, Sean Phelan, Elena Bargagli, Francesco Cinetto, Marco Confalonieri, Paola Confalonieri, Sergio Harari, Fabrizio Luppi, Filippo Martone, Anna Palmieri, Paola Rottoli, Francesco Salton, Ricardo Scarpa, Claudio Tana, Sara Tomassetti, Arata Azuma, Naoki Inui, Yutaro Nakamura, Yoshikazu Inoue, Yoshinori Tanino, Noorul Afidza Muhammad, Frouke van Beek, Lenze den Boer, Karin Boomars, Paul Bresser, Laura Claessen, Marjon Elfferich, Roel Erckens, Sanne van Helmondt, Bekir Karakaya, Jan C Grutters, Elske Hoitsma, Károly Illy, Tim L Jansen, Vivienne Kahlmann, Chris Knoet, Ingrid Korenromp, Ton Lenssen, Karen Maassen Vd Brinkdrs, Johannes Jurgen Mager, Rik Marcellis, Jelle Miedema, Trudeke Möller, Linda A A Moonen, Karen Moor, Rémy L M Mostard, Willemien Nienhuis, Esther Nossent, Michelle Paulus, Rudolf Ponds, George Nossent, Marian Quanjel, Felix Rottenberg, Jonathan S O van de Sande, Ruud Segers, Shalini D Soechitram, AnneLoes van Staa, Bert Strookappe, Martin Swaans, Leon van den Toorn, Marjo J T van de Ven, Mareye Voortman, Adriane Dore Marie Vorselaars, Lenneke Vente, Petal A Wijnen, Marlies Wijsenbeek, Jolanda De Vries, Arthur van Zanten, Michael Durheim, Øystein Rasch-Halvorsen, Anders Tøndell, Anna Dubaniewicz, Wojciech Piotrowski, Bartlomiej Roter, Carlos Robalo Cordeiro, Tiago Alfaro, Irina Strambu, Alexander Vizel, Rafael Cano, Eva Balcells, Diego Castillo, Joel Francesqui, Juan Mañá, Maria Molina, Inigo Ojanguren, Jose Antonio Rodriguez Portal, Jacobo Sellares, Elizabeth Arkema, Pernilla Darlington, Per Eldhagen, Katinka Elfström, Johan Grunewald, Susanna Kullberg, Natalia V Rivera, Marios Rossides, Joanna Werner, Irem Dincer, Gülcan Koç, Canan Yucesan, Ozlem Ozdemir Kumbasar, Surinder Birring, Jeanette Boyd, Leo Casimo, Christopher Huntley, Vasileios Kouranos, Jaqui Newton, Lisa Spencer, Mark Spears, Paula Barreras, Yvette Cozier, Elliott Crouser, Logan Harper, W Ennis James, Lisa Maier, Shu-Yi Liao, Adam Morgenthau, Ogugua Ndili Obi, Divya Patel, Frank Rivera, Milton D Rossman, Michelle Sharp, Maggie Sharma, Jonas C Schupp, Barney J Stern, Nadera Sweiss, Jinny Tavee, Daniel Zank, Galyna Gumeniuk, Volodymyr Gavrysyuk, Levgeniia Merenkova. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis Lancet Respiratory Medicine 2024 Nov;12(11):848-851.(井上義一)
• 67. Kako J,Kobayashi M,Matsuda Y,Inoue S,Tanimukai H,Wada S,Hasegawa T Nonpharmacological Intervention for Delirium in Patients With Cancer: A Scoping Review Journal of Pain and Symptom Management 2024 Nov;68(5):(松田能宣)
• 68. Kanaoka K,Arai T,Takimoto T,Moda M,Shintani R,Ryuge M,Takeuchi N,Kagawa T,Tachibana K,Inoue Y,Sumikawa H,Takeda M,Shimizu S Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study Respiratory investigation 2024 Nov;62(6):1161-1167.(金岡賢輔)
• 69. Kawachi H,Tamiya M,Oya Y,Saito G,Taniguchi Y,Matsumoto H,Sato Y,Otsuki T,Suzuki H,Fukuda Y,Tanaka S,Tsukita Y,Uchida J,Sakata Y,Nakatani Y,Shibaki R,Arai D,Okada A,Hara S,Takayama K,Nishino K Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005) Clinical Lung Cancer 2024 Nov;25(7):643-652.(谷口善彦)
• 70. Yoshida S,Tsuyuguchi K,Kobayashi T,Kurahara Y,Shimatani Y,Arai T Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of Mycobacterium abscessus-related pulmonary disease Respiratory Investigation 2024 Nov;62(6):1142-1148.(𠮷田志緒美)
• 71. Shimoda M,Tanaka Y,Ohe T,Ishiguro T,Suzuki A,Kurahara Y,Shimatani Y,Matsushima H,Kusano K,Ohta H,Yanagisawa S,Kozu Y,Yui T,Igarashi S,Kimizuka Y,Honda K,Otani S,Chiba S,Xu DJ,Mitsui M,Waseda Y,Ishii H Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase Respiratory Investigation 2024 Nov;62(6):963-969.(倉原優)
• 72. Amano K,Koshimoto S,Okamura S,Sakaguchi T,Arakawa S,Matsuda Y,Tokoro A,Takeuchi T,Satomi E,Wada T,Wada M,Yamada T,Mori N Association of Systemic Inflammation with Dietary Intake, Nutrition Impact Symptoms, and Eating-Related Distress Among Patients with Advanced Cancer Healthcare 2024 Dec;12(24):(松田能宣)
• 73. Nii T, Fujiwara K, Kobayashi T, Hagiwara E, Fukushima K, Morimoto K, Tsuyuguchi K, Ogura T, Kida H. Serodiagnosis of M. abscessus species pulmonary disease using anti-glycopeptidolipid-core IgA antibody. IJTLD OPEN 2024 Dec;1(12):575－577.(露口一成)
• 74. Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease Journal of Infection and Chemotherapy 2025 Jan;31(1):102441.(倉原優)
• 75. Sugisaka J,Fujimoto D,Tamiya M,Hata A,Matsumoto H,Yokoyama T,Taniguchi Y,Uchida J,Sato Y,Kijima T,Tanaka H,Furuya N,Masuda T,Sakata Y,Miyauchi E,Saito G,Miura S,Yamaguchi T,Daga H,Sakata S,Yamamoto N,Akamatsu H Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study Lung Cancer 2025 Jan;199(谷口善彦)
• 76. Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clinical Lung Cancer 2025 Jan;26(1):1-8.(田宮朗裕)
• 77. Horinouchi H,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Kozuki T,Tokito T,Oizumi S,Seike M,Ohashi K,Mio T,Sone T,Iwao C,Iwane T,Koto R,Tsuboi M Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study Lung Cancer 2025 Jan;199(安宅信二)
• 78. Arai T,Inoue Y,Akasaka K,Masunaga A,Fujita M,Yamaguchi E,Saigusa M,Murakami K,Kurahara Y,Tsuyuguchi K,Suzuki T,Miyazaki Y,Bando M,Suda T Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 2025 Jan;63(1):20-26.(新井徹)
• 79. Akapelwa M, Kapalamula T, Moonga L, Bwalya P, Solo E, Chizimu J, Thapa J, Hayashida K, Hang’ombe B, Munyeme M, Tamaru A, Wada W, Yoshida S, Kodera T, Kawase M, Gordon S, Yamada K, Nakajima C, Suzuki Y Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) method for differential detection of Mycobacterium bovis and Mycobacterium tuberculosis by dipstick DNA chromatography Microbiology Spectrum 2025 Jan 3;(𠮷田志緒美)
• 80. Inoue Y,Ogura T,Azuma A,Kondoh Y,Homma S,Muraishi K,Ikeda R,Ochiai K,Sugiyama Y,Nukiwa T Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Advances in Therapy 2025 Feb;42(2):1075-1093.(井上義一)
• 81. Takashi Nishihara, Hideo Ishikawa, Kazunari Tsuyuguchi, Shoichi Fukuda, Hiromitsu Sumikawa Reevaluating the Role of Bronchoscopy Prior to Bronchial Artery Embolization in Non-Intubated Patients with Hemoptysis due to Bronchiectasis and Chronic Pulmonary Infection Chest Pulmonary 2025 Mar;online first(西原昂)
• 82. Takimoto T,Takeuchi N,Inoue Y,Arai T Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis PULMONOLOGY 2024 Sep 30;30(5):488-491.(滝本宜之)
• 83. Ozawa Y,Koh Y,Hase T,Chibana K,Kaira K,Okishio K,Ichihara E,Murakami S,Shimokawa M,Yamamoto N Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) Therapeutic Advances in Medical Oncology 2024;16(沖塩協一)
• 84. Kurahara Y,Shimatani Y,Ryuge M,Tsuyuguchi K Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae Internal medicine 2024;63(6):879-880.(倉原優)
• 85. Kurahara Y Tuberculous Bronchostenosis Manifesting as the "CT Angiogram Sign" Internal medicine 2024;63(18):2581-2582.(倉原優)

和文原著・著書等

• 1. 田中 悠也, 倉原 優．病気のはなし 結核検査と技術2024;52(2): 124-128.
• 2. 松田 能宣．不安と呼吸困難呼吸器内科2024;45(4):422～426.
• 3. 倉原 優．論文視点 コロナ肺炎の後遺症3年後も3分の1に病変残存Medical Tribune2024;57(8):3.
• 4. 田中 悠也, 倉原 優, 嶋谷 泰明, 小林 岳彦, 吉田 志緒美, 松本 錦之介, 露口 一成．肺非結核性抗酸菌症から菌交代し肺結核を発症した症例の検討結核2024;99(3):154.
• 5. 倉原 優．膿性痰で分類されていたCOPD増悪の基準に下剋上J-IDEO2024;8(3):504-505.
• 6. 倉原 優．ポケット呼吸器診療2024シーニュ2024;
• 7. 露口一成．非結核性抗酸菌症の微生物学的検査の実際呼吸器内科2024;45(6):566-570.
• 8. 松田能宣．パニック発作
  今夜からもう困らない！夜の症状緩和 南江堂2024;128～135.
• 9. 松田能宣．第Ⅳ章特定集団への緩和ケア 6慢性呼吸器疾患専門家をめざす人のための緩和医療学 南江堂2024;333～336.
• 10. 松田能宣．非がん慢性呼吸器疾患：エビデンスアップデート医学のあゆみ2024;289(10):771～775.
• 11. 倉原 優．エアロゾルと抗酸菌感染症呼吸器内科2024;45(6):623-628.
• 12. 倉原 優．なぜ右の横隔膜が弱いのか？J-IDEO2024;8(4):684-685.
• 13. 新井 徹．肺胞蛋白症呼吸器内科診療の掟2024;502～510.
• 14. 田中 悠也, 倉原 優パルスオキシメータ呼吸器ジャーナル2024;72376-378.
• 15. 田中 悠也, 倉原 優高高度における呼吸生理呼吸器ジャーナル2024;72392-394.
• 16. 田中 悠也, 倉原 優「Happy hypoxia」について再考する呼吸器ジャーナル2024;72491-493.
• 17. 倉原 優、森本耕三「世界気管支拡張症デー」広く病気の認知をJ-BREATH2024;(133):11.
• 18. 倉原 優．肺NTM症とエストロゲン枯渇J-IDEO2024;8(5):834-836.
• 19. 和田佐保、松田能宣、井上真一郎、角甲純、谷向仁【ガイドラインを実践できる,エビデンスと臨床のギャップが埋まる 向精神薬のエビデンスベースドプラクティス】(第2章)いまはこうする!ガイドラインのトリセツ せん妄(解説)薬事2024;66(14):2623-2629.
• 20. 松田能宣．【精神科医として関わるがん治療関連精神症状】進行がんにおける低活動型せん妄の診断と対応(解説)臨床精神薬理2024;27(10):1013-1021.
• 21. 𠮷田志緒美, 山本剛, 石井良和, 御手洗聡抗酸菌検査のアンケート調査2022における結果報告 結核2024;99(6):163-172.
• 22. 田中 悠也, 倉原 優喘息・COPD鑑別が難しい症例の問診・身体所見の実臨床でのコツ（検査に重きを置いて）. jmedmook94 今日の診療に活かせる喘息・COPD ポイント解説.今日の診療に活かせる 喘息・COPDポイント解説2024;
• 23. 倉原 優．慢性肺アスペルギルス症とイサブコナゾールJ-IDEO2024;8(6):982-984.
• 24. 露口一成．肺結核症最新ガイドラインに基づく呼吸器疾患診療指針2024;
• 25. 井上義一．リンパ脈管筋腫症最新ガイドラインに基づく呼吸器疾患診療指針 第６版2024;
• 26. 新井 徹．間質性肺炎の診断と地域連携Medical Practice2025;42(1):50～54.
• 27. 倉原 優．見逃したくない縦隔炎J-IDEO2025;9(1):62-64.
• 28. 𠮷田志緒美．検査材料抗酸菌検査ガイド20252025;31-36.
• 29. 井上義一．肺胞蛋白症呼吸器疾患最新の治療2025-20262025;
• 30. 蓮尾英明、松岡弘道、松田能宣緩和ケアにおける悩ましい感情のひも解き方Difficult Patient2025;
• 31. 倉原 優．「肺NTM症の診断基準」の改訂J-IDEO2025;9(2):282-283.
• 32. 𠮷田志緒美．病理組織標本で抗酸菌が観察されていますが，培養で発育しないと言われました．どのような抗酸菌を想定し，追加対応はどのようにすればよいでしょうか？臨床検査2025増大号 「さっと読めてぱっとわかる！感染症診断メモ」2025;69(4):

2024年12月27日掲載

2023年度英文論文

• 1. Hoshida Y, Tsujii A, Ohshima S, Saeki Y, Yagita M, Miyamura T, Katayama M, Kawasaki T, Hiramatsu Y, Oshima H, Murayama T, Higa S, Kuraoka K, Hirano F, Ichikawa K, Kurosawa M, Suzuki H, Chiba N, Sugiyama T, Minami Y, Niino H, Ihata A, Saito I, Mitsuo A, Maejima T, Kawashima A, Tsutani H, Takahi K, Kasai T, Shinno Y, Tachiyama Y, Teramoto N, Taguchi K, Naito S, Yoshizawa S, Ito M, Suenaga Y, Mori S, Nagakura S, Yoshikawa N, Nomoto M, Ueda A, Nagaoka S, Tsuura Y, Setoguchi K, Sugii S, Abe A, Sugaya T, Sugahara H, Fujita S, Kunugiza Y, Iizuka N, Yoshihara R, Yabe H, Fujisaki T, Morii E, Takeshita M, Sato M, Saito K, Matsui K, Tomita Y, Furukawa H, Tohma S. Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders. Arthritis & Rheumatology. 2024 45364;(笠井孝彦)
• 2. Kurahara Y, Okamori H, Tsuyuguchi K. A Large Cavity Associated with Pulmonary Infarction. Internal Medicine. 2024 MAR;(倉原優)
• 3. Isobe K, Nakamura Y, Sakamoto S, Tomii K, Takimoto T, Miyazaki Y, Matsumoto M, Sugino K, Ichikado K, Moriguchi S, Yamaguchi K, Baba T, Ozasa H, Igata F, Anabuki K, Homma S, Date H, Suda T, Kishi K. Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia. ERJ Open Research. 2024 45352;10(2):00981-2023.(滝本宜之)
• 4. Molina TJ, Roden AC, Szolkowska M, Shimizu S, Moreira AL, Chalabreysse L, Besse B, de Montpr V, Marom EM, Detterback F, Girard N, Nicholson AG, Marx A. International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study. Lung Cancer. 2024 MAR;189(清水重喜)
• 5. Simon L F Walsh, Jan De Backer, Helmut Prosch, Georg Langs, Lucio Calandriello, Vincent Cottin, Kevin K Brown, Yoshikazu Inoue, Vasilios Tzilas, Elizabeth Estes. Towards the adoption of quantitative computed tomography in the management of interstitial lung disease. European Respiratory Review. 2024 Mar;33(171):(井上義一)
• 6. Akira M, Suganuma N. Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia. CANADIAN RESPIRATORY JOURNAL. 2024 45336;2024(審良正則)
• 7. Tanaka Y, Kobayashi T, Shimizu S, Kurahara Y. Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug. Internal Medicine. 2024 Feb;(田中悠也)
• 8. Takaaki Hasegawa, Toru Okuyama, Takehiro Uemura, Yoshinobu Matsuda, Hiroyuki Otani, Junichi Shimizu, Yoshitsugu Horio, Naohiro Watanabe, Teppei Yamaguchi, Satoshi Fukuda, Tetsuya Oguri, Ken Maeno, Yoshihiko Taniguchi, Kaname Nosaki, Kensuke Fukumitsu, Tatsuo Akechi. Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer. ONCOLOGIST. 2024 FEB;29(2):e282-e289.(谷口善彦)
• 9. Ryota Shibaki, Daichi Fujimoto, Tsukasa Nozawa, Akira Sano, Yuka Kitamura, Junya Fukuoka, Yuki Sato, Takashi Kijima, Hirotaka Matsumoto, Toshihide Yokoyama, S.atoru Miura, Akito Hata, Motohiro Tamiya, Yoshihiko Taniguchi, Jun Sugisaka, Naoki Furuya, Hisashi Tanaka, Nobuyuki Yamamoto, Yasuhiro Koh, Hiroaki Akamatsu Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer. Journal for immunotherapy of cancer. 2024 FEB;12(2):(谷口善彦)
• 10. Mitsudomi T, Ito H, Okada M, Sugawara S, Shio Y, Tomii K, Okami J, Sakakura N, Kubota K, Takamochi K, Atagi S, Tsuboi M, Oizumi S, Ikeda N, Ohde Y, Ntambwe I, Mahmood J, Cai JL, Tanaka F. Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816. Cancer science. 2024 FEB;115(2):540-554.(安宅信二)
• 11. Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen-Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nishio. NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Molecular Oncology. 2024 FEB;18(2):305-316.(沖塩協一)
• 12. Kagawa T, Kurahashi K, Seki T, Kawasaki Y, Nahara I, Takeda C, Yonekura H, Tanaka S, Kawakami K. The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database. Journal of Anesthesia. 2024 FEB;38(1):92-97.(香川智子)
• 13. Kurahara Y. Tuberculous Bronchostenosis Manifesting as the CT Angiogram Sign. Internal Medicine. 2024 Feb;(倉原優)
• 14. Marlies Wijsenbeek, Jeffrey J Swigris, Yoshikazu Inoue, Michael Kreuter, Toby M Maher, Takafumi Suda, Michael Baldwin, Heiko Mueller, Klaus B Rohr, Kevin R Flaherty. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. European Respiratory Journal. 2024 feb;63(2):(井上義一)
• 15. Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins RG, Nathan SD, Raghu G, Walsh SLF, Jayia PK, Kamath N, Martinez FJ. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial. American Journal of Respiratory and Critical Care Medicine. 2024 Feb;209(9):1132-1140.(井上義一)
• 16. Y. Kurahara, Y. Tanaka, T. Kobayashi, S. Yoshida, K. Tsuyuguchi. Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease. Journal of Infection and Chemotherapy. 2024 Jan;(倉原優)
• 17. Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa, Kana Hashimoto, Yosuke Kawashima, Tomohiro Sakamoto, Hiroshi Wakui, Shuji Murakami, Kyoichi Okishio, Kenji Hayashihara, Yuichiro Ohe, Tokyo Cooperative Oncology Group (TCOG). First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial. JAMA oncology. 2024 JAN;10(1):43-51.(沖塩協一)
• 18. Tomioka H, Miyazaki Y, Inoue Y, Egashira R, Kawamura T, Sano H, Johkoh T, Takemura T, Hisada T, Fukuoka J, Comm Japanese Resp Soc Japane. Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Respiratory Investigation. 2024 JAN;62(1):16-43.(井上義一)
• 19. Akihiro Tamiya. Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors. Respiratory investigation. 2024 JAN;62(1):85-89.(田宮朗裕)
• 20. Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma. Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer Research Communications. 2024 JAN;4(1):226-235.(沖塩協一)
• 21. Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Eiki Ichihara, Shuji Murakami, Mototsugu Shimokawa, Nobuyuki Yamamoto. Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L). Therapeutic Advances in Medical Oncology. 2024 JAN;16(沖塩協一)
• 22. Kurahara Y, Shimatani Y, Ryuge M, Tsuyuguchi K. Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae. Internal Medicine. 2024;63(6):879-880.(倉原優)
• 23. Kinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, Toshiyuki Minami, Yuhei Kinehara, Akihiro Tamiya, Yasuhiko Suga, Tomoki Kuge, Masahide Mori, Hidekazu Suzuki, Satoshi Tobita, Kiyonobu Ueno, Yoshinobu Namba, Satoshi Tetsumoto, Toshie Niki, Osamu Morimura, Akio Osa, Kazumi Nishino, Izumi Nagatomo, Yoshito Takeda, Takashi Kijima, Atsushi Kumanogoh. Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study. Cancer Immunology Immunotherapy. 2024 JAN;73(1):4.(田宮朗裕)
• 24. Takehiko Kobayashi, Kazunari Tsuyuguchi, Tomoko Kagawa, Toru Arai, Yoshikazu Inoue. Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis. Journal of infection and chemotherapy. 2024 JAN;30(1):45484.(小林岳彦)
• 25. Takimoto T, Takeuchi N, Inoue Y, Arai T. Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis. Pulmonology. 2024 Jan;(滝本宜之)
• 26. Yoshinobu Matsuda, Hideaki Hasuo, Keiichi Narita, Hiromichi Matsuoka, Ryo Morita, Daisuke Kiuchi  Tomoo Ikari, Tetsuo Hori, Koya Okazaki, Kiyohiro Sakai, Sayo Aiki, Hiroko Okabayashi, Shunsuke Oyamada, Keisuke Ariyoshi, Akihiro Tokoro, Mikihiko Fukunaga. Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study. BMJ Supportive & Palliative Care. 2024 jan;13(3):1126-1123.(松田能宣)
• 27. Okamoto M, Fujimoto K, Johkoh T, Kawaguchi A, Mukae H, Sakamoto N, Ogura T, Ikeda S, Kondoh Y, Yamano Y, Komiya K, Umeki K, Nishikiori H, Tanino Y, Tsuda T, Arai N, Komatsu M, Sakamoto S, Yatera K, Inoue Y, Miyazaki Y, Hashimoto S, Shimizu Y, Hozumi H, Ohnishi H, Handa T, Hattori N, Kishaba T, Kato M, Inomata M, Ishii H, Hamada N, Konno S, Zaizen Y, Azuma A, Suda T, Izuhara K, Hoshino T. A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib. Scientific reports. 2023 45653;13(1):(井上義一)
• 28. Atsushi Yanagisawa, Akihiro Tamiya, Takayuki Takimoto, Hiromitsu Sumikawa. Generalized lymphatic anomaly involving the pleura and bone in an older male: A case report. Respiratory Medicine Case Reports. 2023 DEC;46101961.(柳澤篤)
• 29. Junko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, Makoto Takahama, Hiroyasu Shoda, Atsushi Nakamura, Yoshitaka Kitamura, Nobuaki Mamesaya, Yoshihisa Kadota, Kenji Sawa, Kyoichi Okishio, Morihito Okada, Chihiro Suminaka, Kenta Noda, Kazuko Sakai, Yasutaka Chiba, Kazuto Nishio, Kenji Chamoto, Tasuku Honjo, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Hidetoshi Hayashi. Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy. JTO CLINICAL AND RESEARCH REPORTS. 2023 DEC;4(12):(沖塩協一)
• 30. Arai T, Takimoto T, Takeuchi N, Minomo S, Kagawa T, Inoue Y. Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 2023 DEC;12(23):(新井徹)
• 31. Morikawa M, Kajiwara K, Kobayashi M, Yusuke K, Nakano K, Matsuda Y, Shimizu Y, Shimazu T, Kako J. Nursing Support for Pain in Patients With Cancer: A Scoping Review. Cureus Journal of Medical Science. 2023 45626;15(11):(松田能宣)
• 32. Samejima H, Kojima K, Fujiwara A, Tokunaga T, Okishio K, Yoon H. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study. BMC Cancer. 2023 45610;23(1):(鮫島弘睦)
• 33. Kobayashi M, Kajiwara K, Morikawa M, Kanno Y, Nakano K, Matsuda Y, Shimizu Y, Shimazu T, Kako J. Nursing Support for Nausea and Vomiting in Patients With Cancer: A Scoping Review. Cureus Journal of Medical Science. 2023 45599;15(11):(松田能宣)
• 34. Yanagisawa A, Takimoto T, Kurahara Y, Tsuyuguchi K, Yoshida S, Hirose M, Inoue Y, Arai T. A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy. Internal Medicine. 2023 Nov;2847-23.(柳澤篤)
• 35. Hideo Ishikawa, Yu Yamaguchi, Takashi Nishihara, Naoki Omachi, Misaki Ryuge, Kazushi Kitaguchi, Tomoaki Hattori. A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion. Respiratory Endoscopy. 2023 Nov;1(2):28-41.(西原昂)
• 36. Akihiro Tamiya, Kensuke Kanaoka, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Kyoichi Okishio, Maiko Takeda, Takahiko Kasai, Shigeki Shigeki. Enhancing tumour content and tumour cell count using microdissection contributes to higher detection rate of genetic mutations by next-generation sequencers. Heliyon. 2023 Nov;9(11):(田宮朗裕)
• 37. Kurahara Y, Kanaoka K, Tanaka Y, Maeda Y, Kobayashi T, Takeuchi N, Kagawa T, Tachibana K, Yoshida S, Tsuyuguchi K. Management of dysphonia caused by amikacin liposome inhalation in M. avium complex pulmonary disease. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023 45597;27(11):872-873.(倉原優)
• 38. Hironobu Samejima, Naoko Ose, Hideki Nagata, Soichiro Funaki & Yasushi Shintani. Thoracoscopic sublobar resection for congenital bronchial atresia in adults: a report of three cases. General Thoracic and Cardiovascular Surgery Cases. 2023 Nov;(鮫島弘睦)
• 39. Kajiwara K, Kobayashi M, Morikawa M, Kanno Y, Nakano K, Matsuda Y, Shimizu Y, Shimazu T, Kako J. Nursing Support for Caregiver Burden in Family Caregivers of Patients With Cancer: A Scoping Review. American journal of hospice & palliative care. 2023 Nov;13(10):e075024.(松田能宣)
• 40. Hamamoto Y, Kawamura M, Uchida H, Hiramatsu K, Katori C, Asai H, Shimizu S, Egawa S, Yoshida K. The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2023 45590;(清水重喜)
• 41. Minako Shimaya, Yuji Inagaki, Toru Arai, Mayu Kawakami, Naoko Takeuchi, Hiromitsu Sumikawa, Shigeki Shimizu, Takayuki Takimoto, Yoshikazu Inoue. Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome: A Case Report. Internal Medicine. 2023 OCT;(島矢未奈子)
• 42. Atagi S, Daimon T, Okishio K, Komuta K, Okano Y, Minato K, Kim YH, Usui R, Tabata C, Tamura A, Kawahara M. A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01. Thoracic cancer. 2023 OCT;14(29):2941-2949.(沖塩協一)
• 43. Kobayashi Y, Arai H, Hamamoto Y, Yoshida K, Shimizu S, Yasuhara Y, Ichimaru N. High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy. CLINICAL GENITOURINARY CANCER. 2023 OCT;21(5):E386-E393.(清水重喜)
• 44. Taniguchi Y, Tamiya A, Matsuda Y, Adachi Y, Enomoto T, Azuma K, Kouno S, Tokoro A, Atagi S. Opioids impair nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer. BMJ Supportive & Palliative Care. 2023 OCT;13(E1):E185-E189.(谷口善彦)
• 45. Yuhei Kinehara, Takayuki Shiroyama, Akihiro Tamiya, Motohiro Tamiya, Seigo Minami, Masaki Kanazu, Osamu Morimura, Toshie Niki, Satoshi Tetsumoto, Yoshihiko Taniguchi, Tomoki Kuge, Kazumi Nishino, Izumi Nagatomo, Atsushi Kumanogoh, Isao Tachibana. Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC. JTO CLINICAL AND RESEARCH REPORTS. 2023 OCT;4(11):100586.(田宮朗裕)
• 46. Masayuki Imajoh, Shiomi Yoshida, Lisa Nonaka, Yukari Fukushima, Chie Nakajima, Yasuhiko Suzuki, Takayuki Wada. Retrospective identification of pathogenic mycobacterial species in fish: Mycobacterium pseudoshottsii YM-3, isolated from a yellowtail fish in 1986 in Kochi, Japan. Microbiology Resource Announcements. 2023 OCT;12(10):00498-23.(吉田志緒美)
• 47. Fukuda T, Egashira R, Ueno M, Hashisako M, Sumikawa H, Tominaga J, Yamada D, Fukuoka J, Misumi S, Ojiri H, Hatabu H, Johkoh T. Stepwise diagnostic algorithm for high-attenuation pulmonary abnormalities on CT. Insights into Imaging. 2023 OCT;14(1):177.(澄川裕充)
• 48. Kensuke Kanaoka, Hiromitsu Sumikawa, Shunsuke Oyamada, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Kyoichi Okishio. Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib. BMC cancer. 2023 Sep;23(1):834.(金岡賢輔)
• 49. Takimoto T, Yanagisawa A, Arai T, Inoue Y. Vocal cord paralysis associated with pleuroparenchymal fibroelastosis: A case report and literature review. Respiratory Investigation. 2023 Sep;61(5):548-552.(滝本宜之)
• 50. Matsuda Y, Tanimukai H, Inoue S, Hirayama T, Kanno Y, Kitaura Y, Inada S, Sugano K, Yoshimura M, Harashima S, Wada S, Hasegawa T, Okamoto Y, Dotani C, Takeuchi M, Kako J, Sadahiro R, Kishi Y, Uchida M, Ogawa A, Inagaki M, Okuyama T. A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023 45534;53(9):808-822.(松田能宣)
• 51. Kataoka K, Oda K, Takizawa H, Ogura T, Miyamoto A, Inoue Y, Akagawa S, Hashimoto S, Kishaba T, Sakamoto K, Hamada N, Kuwano K, Nakayama M, Ebina M, Enomoto N, Miyazaki Y, Atsumi K, Izumi S, Tanino Y, Ishii H, Ohnishi H, Suda T, Kondoh Y. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy. Scientific reports. 2023 45526;13(1):(井上義一)
• 52. Kurahara Y, Tsuyuguchi K. Aspiration Pneumonitis Caused by Gargling with 10% (w/v) Benzalkonium Chloride Proven by Mixing with an Anionic Surfactant. Respiratory Endoscopy. 1(2):75-77.(倉原優)
• 53. Atsushi Yanagisawa, Takayuki Takimoto, Ryota Shintani, Takehiko Kobayashi, Masaki Hirose, Toru Arai, Yoshikazu Inoue. Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode. Internal Medicine. 2023 AUG;62(15):2237-2241.(柳澤篤)
• 54. Takehiko Kobayashi, Kazunari Tsuyuguchi, Shiomi Yoshida, Toru Arai, Yoshikazu Inoue. Cases of severe Mycobacterium avium lung disease occurred in a married couple caused by identical strain. Journal of infection and chemotherapy. 2023 AUG;29(8):812-815.(小林岳彦)
• 55. Takagi Y, Sato J, Yamamoto Y, Matsunuma R, Watanabe H, Mori M, Hasegawa T, Matsuda Y, Kako J, Kasahara Y, Goya S, Kohara H, Nakayama T, Yamaguchi T. Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis. International Journal of Clinical Oncology. 2023 AUG;28(8):999-1010.(松田能宣)
• 56. Shunichi Sugawara, Kentaro Tanaka, Fumio Imamura, Nobuyuki Yamamoto, Makoto Nishio, Kyoichi Okishio, Tomonori Hirashima, Hiroshi Tanaka, Tatsuro Fukuhara, Yasuharu Nakahara, Takayasu Kurata, Nobuyuki Katakami, Morihito Okada, Hidehito Horinouchi, Hibiki Udagawa, Kazuo Kasahara, Miyako Satouchi, Hideo Saka, Takaaki Tokito, Yukio Hosomi, Keisuke Aoe, Kazuma Kishi, Kadoaki Ohashi, Takuma Yokoyama, Noriaki Adachi, Kazuo Noguchi, Paul Schwarzenberger, Terufumi Kato. Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407. Cancer science. 2023 AUG;114(8):3330-3341.(沖塩協一)
• 57. Sadahiro R, Hatta K, Yamaguchi T, Masanori E, Matsuda Y, Ogawa A, Iwata Y, Tokoro A, Nakahara R, Hirayama T, Yanai Y, Ogawa Y, Kayano A, Ariyoshi K, Oyamada S, Uchitomi Y, Akechi T, Yamamoto N, Okita N, Yorikane E, Shimada K, Furukawa T, Hashimoto H, Maeda M, Sato T, Sekimoto A, Sasaki C, Saito E, Uezono Y, Matsuoka H. A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023 Aug;53(9):851-857.(松田能宣)
• 58. Mori M, Yamaguchi T, Suzuki K, Matsuda Y, Matsunuma R, Watanabe H, Ikari T, Matsumoto Y, Imai K, Yokomichi N, Miwa S, Yamauchi T, Okamoto S, Inoue S, Inoue A, Hui D, Morita T, Satomi E. Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023 Aug;66(2):e177-e184.(松田能宣)
• 59. Jun Kako, Miharu Morikawa, Masamitsu Kobayashi, Yusuke Kanno, Kohei Kajiwara, Kimiko Nakano, Yoshinobu Matsuda, Yoichi Shimizu, Megumi Hori, Mariko Niino, Miho Suzuki, Taichi Shimazu. Nursing support for breathlessness in patients with cancer: a scoping review. BMJ Open. 2023 Oct;13(10):(松田能宣)
• 60. Kanaoka K, Minami S. Elevation of serum lactate dehydrogenase during methylprednisolone pulse therapy as a predictor of high mortality in acute respiratory failure: A single-center, retrospective study. SAGE Open Medicine. 2023 Aug;(金岡賢輔)
• 61. Yu Kurahara, Yasuaki Shimatani. Melanoptysis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. 2023 JUL;116(7):540-541.(倉原優)
• 62. Shimokawa T, Okamoto H, Machida R, Misumi Y, Hosomi Y, Yoneshima Y, Tanaka H, Okishio K, Simizu J, Goto K, Akamatsu H, Kubota K, Nakagawa K, Horinouchi H, Ando M, Kataoka T, Ohe Y. Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial. Lung Cancer. 2023 JUL;181(沖塩協一)
• 63. Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya, Hiroshi Gyotoku, Shuji Murakami, Yoshihito Kogure, Daijiro Harada, Kyoichi Okishio, Hiroaki Okamoto, Yasushi Goto. Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study). Future Oncology. 2023 JUL;19(22):1515-1521.(沖塩協一)
• 64. T. Arai, Y. Kurahara, M. Moda, T. Kobayashi, Y. Matsuda, T. Kagawa, R. Sugawara, K. Tsuyuguchi, Y. Inoue. COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy. Journal of Clinical Medicine. 2023 JUL;12(15):4940.(新井徹)
• 65. Khor YH, Cottin V, Holland AE, Inoue Y, McDonald VM, Oldham J, Renzoni EA, Russell AM, Strek ME, Ryerson CJ. Treatable traits: a comprehensive precision medicine approach in interstitial lung disease. European Respiratory Journal. 2023 45474;62(1):(井上義一)
• 66. Hasegawa T, Ochi T, Goya S, Matsuda Y, Kako J, Watanabe H, Kasahara Y, Kohara H, Mori M, Nakayama T, Yamaguchi T. Efficacy of supplemental oxygen for dyspnea relief in patients with advanced progressive illness: A systematic review and meta-analysis. Respiratory Investigation. 2023 Jul;61(4):418-437.(松田能宣)
• 67. Otani H, Amano K, Morita T, Miura T, Mori N, Tatara R, Kessoku T, Tokoro A, Tagami K, Mori M, Taniyama T, Nakajima N, Nakanishi E, Kako J, Miyashita M. Difficulty swallowing and food bolus obstruction in advanced cancer: association with the cachexia-related quality of life. Annals of Palliative Medicine. 2023 Jul;12(4):717-728.(所昭宏)
• 68. Tetsuya Komatsu, Kenji Ohya, Atsushi Ota, Yukiko Nishiuchi, Hirokazu Yano, Kayoko Matsuo, Justice Opare Odoi, Shota Suganuma, Kotaro Sawai, Akemi Hasebe, Tetsuo Asai, Tokuma Yanai, Hideto Fukushi, Takayuki Wada, Shiomi Yoshida, Toshihiro Ito, Kentaro Arikawa, Mikihiko Kawai, Manabu Ato, Anthony D. Baughn, Tomotada Iwamoto, Fumito Maruyama. Unique genomic sequences in a novel Mycobacterium avium subsp. hominissuis lineage enable fine scale transmission route tracing during pig movement. One Health. 2023 JUN;16100559.(吉田志緒美)
• 69. Mori M, Miwa S, Ikari T, Kako J, Hasegawa T, Matsunuma R, Suzuki K, Matsuda Y, Watanabe H, Morita T, Yamaguchi T. Current Management Options for Dyspnea in Cancer Patients. Current Treatment Options in Oncology. 2023 Jun;24(6):565-579.(松田能宣)
• 70. Felix Chua 1, Suying Low 2, Gin Tsen Chai 3, Yoshikazu Inoue 4, Voon Ong 5, Amornpun Wongkarnjana 6, Kamon Kawkitinarong 6, Jin Woo Song 7, Zuhanis Abdul Hamid 8, Aida Abdul Aziz 9, Mae Campomanes 10, Toby M Maher 11, Philip L Molyneaux 12, Syazatul Syakirin. Knowledge gaps in fibrotic interstitial lung disease in pan-Asian populations: data not missing at random?. Lancet Respiratory Medicine. 2023 Jun;11(6):502-504.(井上義一)
• 71. Imai K, Morita T, Mori M, Kiuchi D, Yokomichi N, Miwa S, Okamoto S, Yamauchi T, Naito AS, Matsuda Y, Maeda I, Sugano K, Ikenaga M, Inoue S, Satomi E. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023 JUN;65(6):479-489.(松田能宣)
• 72. Goto Y, Kenmotsu H, Tamiya M, Murakami S, Kurata T, Yanagitani N, Taniguchi H, Kuyama S, Shimizu J, Yokoyama T, Shimada N, Maeda T, Tamiya A, Uchiyama A, Imaizumi K, Takahama T, Kato T, Hayashi H, Shiraiwa N, Toyoizumi S, Kikkawa H, Thomaidou D, Nishio M. A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan. JTO CLINICAL AND RESEARCH REPORTS. 2023 MAY;4(5):100508.(田宮朗裕)
• 73. Yuji Inagaki. Factors Other Than Low-Dose Computed Tomography Screening Related to Stage Shift and Improved Survival of Lung Cancer. Journal of Thoracic Oncology. 2023 MAY;18(5):e48-e49.(稲垣雄士)
• 74. Tomoki Kuge, Takayuki Shiroyama, Akihiro Tamiya, Motohiro Tamiya, Masaki Kanazu, Yuhei Kinehara, Tsunehiro Tanaka, Osamu Morimura, Yoshihiko Taniguchi, Toshie Niki, Satoshi Tetsumoto, Kazuhiko Hayashi, Kazumi Nishino, Izumi Nagatomo, Atsushi Kumanogoh. Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC. JTO Clinical and Research Reports. 2023 MAY;4(5):100505.(田宮朗裕)
• 75. Miyashita K, Hozumi H, Inoue Y, Suzuki T, Suda T. Nationwide survey of adult patients with pulmonary alveolar proteinosis using the National Database of designated intractable diseases of Japan. Respiratory Investigation. 2023 MAY;61(3):364-370.(井上義一)
• 76. Yoshihiko Taniguchi, Akihiro Tamiya, Atsushi Yanagisawa, Minako Shimaya, Mayu Kawakami, Yuji Inagaki, Nobuhiko Saijo, Yoshinobu Matsuda, Kyoichi Okishio. Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report. Thoracic cancer. 2023 MAY;14(13):1201-1203.(谷口善彦)
• 77. Peljto AL, Blumhagen RZ, Walts AD, Cardwell J, Powers J, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Vasakova MK, Bendstrup E, Davidsen JR, Borie R, Crestani B, Dieude P, Bonella F, Costabel U, Gudmundsson G, Donnelly SC, Egan J, Henry MT, Keane MP, Kennedy MP, McCarthy C, McElroy AN, Olaniyi JA, O'Reilly KMA, Richeldi L, Leone PM, Poletti V, Puppo F, Tomassetti S, Luzzi V, Kokturk N, Mogulkoc N, Fiddler CA, Hirani N, Jenkins RG, Maher TM, Molyneaux PL, Parfrey H, Braybrooke R, Blackwell TS, Jackson PD, Nathan SD, Porteous MK, Brown KK, Christie JD, Collard HR, Eickelberg O, Foster EE, Gibson KF, Glassberg M, Kass DJ, Kropski JA, Lederer D, Linderholm AL, Loyd J, Mathai SK, Montesi SB, Noth I, Oldham JM, Palmisciano AJ, Reichner CA, Rojas M, Roman J, Schluger N, Shea BS, Swigris JJ, Wolters PJ, Zhang Y, Prele CMA, Enghelmayer JI, Otaola M, Ryerson CJ, Salinas M, Sterclova M, Gebremariam TH, Myllärniemi M, Carbone RG, Furusawa H, Hirose M, Inoue Y, Miyazaki Y, Ohta K, Ohta S, Okamoto T, Kim DS, Pardo A, Selman M, Aranda AU, Park MS, Park JS, Song JW, Molina-Molina M, Planas-Cerezales L, Westergren-Thorsson G, Smith AV, Manichaikul AW, Kim JS, Rich SS, Oelsner EC, Barr RG, Rotter JI, Dupuis J, O'Connor G, Vasan RS, Cho MH, Silverman EK, Schwarz MI, Steele MP, Lee JS, Yang IV, Fingerlin TE, Schwartz DA, Nhlbi Trans Omics Precision Med. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. American Journal of Respiratory and Critical Care Medicine. 2023 45413;207(9):1194-1202.(広瀬雅樹)
• 78. Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Suzuki K, Oyamada S, Ariyoshi K, Kihara K, Mori M. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023 MAY;65(5):400-408.(松田能宣)
• 79. Tachibana K, Akira M, Arai T, Sugimoto C, Hayashi S, Inoue Y. Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis. CANADIAN RESPIRATORY JOURNAL. 2023 45397;2023(Article ID 3624344):45299.(橘和延)
• 80. Takimoto T, Sumikawa H, Arai T, Inoue Y. Left Vocal Cord Paralysis in Idiopathic Pleuroparenchymal Fibroelastosis: A Case Report. JMA Journal. 2023 45396;6(2):220-222.(滝本宜之)
• 81. Megumu Osaki, Takehiko Kobayashi, Shiomi Yoshida, Shigeki Shimizu, Kazunari Tsuyuguchi. Mycobacterium avium Pleurisy with Bronchopleural Fistula Resulting in Rapidly Progressive Respiratory Failure Diagnosed by Transbronchial Autopsy. Internal medicine. 2023 APR;62(8):1237-1241.(吉田志緒美)
• 82. Satoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, Yoshihiko Taniguchi, Yoshinobu Matsuda, Junji Uchida, Kiyonobu Ueno, Hayato Kawachi, Motohiro Tamiya, Takafumi Yanase, Hidekazu Suzuki, Kyoichi Okishio. Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European journal of clinical pharmacology. 2023 APR;79(4):503-511.(田宮朗裕)
• 83. Takeuchi S, Kubota K, Sugawara S, Teramukai S, Noro R, Fujikawa K, Hirose T, Atagi S, Minami S, Iida S, Kuraishi H, Aiba T, Minegishi Y, Matsumoto M, Seike M, Gemma A, Kawahara M. Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01). Cancer Medicine. 2023 Apr;12(8):9133-9143.(安宅信二)
• 84. K. Morimoto; M. Nonaka; Y. Yamazaki; T. Nakagawa; J. Takahashi; K. Tsuyuguchi; S. Kitada; Z. Jumadilova; D. W. Yuen; M. Ciesielska; N. Haasegawa. Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study. Respiratory Investigation. 2024 MAR;62(2):284-290.(露口一成)
• 85. Akihiro Tamiya, Motohiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Takahisa Kawamura, Kei Kunimasa, Takako Inoue, Kazumi Nishino, Kyoichi Okishio. Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting. Anticancer Research. 2023 MAR;43(3):1325-1330.(田宮朗裕)
• 86. Kagawa T, Nagano H, Iwasaku M, Kawano R, Hirayama Y, Uraguchi K, Yoshioka T. Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use?: A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease. Chest. 2023 MAR;3(163):e147-e148.(香川智子)
• 87. Daichi Fujimoto, Satoru Miura, Keisuke Tomii, Hiromitsu Sumikawa, Kenichi Yoshimura, Kazushige Wakuda, Yuko Oya, Toshihide Yokoyama, Takashi Kijima, Tetsuhiko Asao, Motohiro Tamiya, Atsushi Nakamura, Hiroshige Yoshioka, Takaaki Tokito, Shuji Murakami, Akihiro Tamiya, Hiroshi Yokouchi, Satoshi Watanabe, Ou Yamaguchi, Ryotaro Morinaga, Takayuki Jodai, Kentaro Ito, Yoshimasa Shiraishi, Yoshihito Kogure, Ryota Shibaki, Nobuyuki Yamamoto. Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer. Scientific reports. 2023 Mar;13(1):3698.(田宮朗裕)
• 88. Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue. Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation. Journal of Thoracic Disease. 2023 FEB;15(2):300-310.(新井徹)
• 89. Kensuke Kanaoka, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Maiko Takeda, Yoshinobu Matsuda, Kyoichi Okishio, Shigeki Shimizu. Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation. Anticancer Research. 2023 JUN;43(6):2771-2776.(金岡賢輔)
• 90. Kensuke Kanaoka, Shoich Fukuda, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Akihiro Tamiya, Yoshinobu Matsuda, Kyoichi Okishio. Right-sided vocal cord paralysis following stereotactic body radiation therapy for non-small-cell lung cancer: A case report. Thoracic cancer. 2023 JUN;14(16):1534-1537.(金岡賢輔)

和文原著・著書等

• 1. 松田能宣.非がん性呼吸器疾患の緩和ケア. 日本内科学会雑誌. 2024;112(3):531-536.
• 2. 露口一成.結核医療に関する課題. 結核医療の基準とその解説. 2024;
• 3. 新井徹.呼吸器ジャーナル「慢性間質性肺炎を呈する膠原病の急性増悪の診断と治療」. 膠原病内科 呼吸器内科とリウマチ膠原病内科、見えている景色はどう違うか？. 2024;
• 4. 茂田光弘.治りにくい肺炎に出会ったときに疑うべき鑑別診断. 臨床雑誌 内科. 2024;133(2):193-7.
• 5. 田中悠也,倉原優.病気のはなし 結核. 検査と技術. 2024;52(2): 124-128.
• 6. 新井徹.急性増悪の臨床病態と予後1）特発性肺線維症. 呼吸器内科. 2024;45(1):6～14.
• 7. 谷向仁,井上真一郎,松田能宣.がん患者におけるせん妄ガイドライン2022年版 -2019年版からの改定ポイントと今後の取り組みについて-. 腫瘍内科. 2024;33(1):65-70.
• 8. 倉原優.「結核の統計2023」を読み解く. J-IDEO. 2024;8(1):89-91.
• 9. 倉原優.クロファジミンの処方例が増えてきた. J-IDEO. 2024;8(2):321-323.
• 10. 合屋将,中野泰,十九浦宏明,高木雄亮,渡邊紘章,松田能宣,角甲純,笠原庸子,小原弘之,森雅紀,中山健夫,山口崇.低酸素血症があり呼吸困難を有する進行性疾患患者に対する高流量鼻カニュラ酸素療法の有効性 システマティックレビュー(原著論文). Palliative Care Research. 2023;18(4):261-269.
• 11. 西原昂.A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion 呼吸器科医のためのコイルによる気管支動脈塞栓術の技術マニュアル:専門家の意見.Respiratory Endoscopy（一般社団法人 日本呼吸器内視鏡学会）. 2023;1(2):28-41.
• 12. 倉原優.Aspiration Pneumonitis Caused by Gargling with 10% (w/v) Benzalkonium Chloride Proven by Mixing with an Anionic Surfactant 10%(w/v)塩化ベンザルコニウムを用いたうがいによる誤えん性肺炎が,陰イオン界面活性剤と混合することによって証明された1例. Respiratory Endoscopy（一般社団法人 日本呼吸器内視鏡学会）. 2023;1(2):75-77.
• 13. 新井徹.希少疾患. 呼吸器内科学レビュー2024-2025（総合医学社）. 2023;
• 14. 鮫島弘睦.Thoracoscopic sublobar resection for congenital bronchial atresia in adults: a report of three cases. General Thoracic and Cardiovascular Surgery Cases. 2023;
• 15. 奥田有香麻酔科,栗山俊之,月山淑,松田能宣,山口崇,森雅紀,下川敏雄,川股知之.呼吸困難のコントロールがオピオイドのみでは難しくミダゾラムを併用した終末期がん患者の要因(原著論文). Palliative Care Research. 2023;8(4):247-252.
• 16. 倉原優.あなどるなかれアミノグリコシドの難聴. J-IDEO. 2023;7(6):896-897.
• 17. 井上義一.リンパ脈管筋腫症（私の治療）. WEB医事新報. 医事新報社. 2023;
• 18. 松田能宣.身体疾患にともなう抑うつ,不安 呼吸器疾患にともなう抑うつ,不安. 心身医学. 2023;63(6):520-524.
• 19. 倉原優.Survival 35 喘息発作・COPD増悪のときの全身性ステロイドはいつまで使えばいいの？ 研修医サバイバルブック.  2023;
• 20. 田中悠也,今尾舞,難波晃平,藤本佑樹,池内美貴,山本浩生,橋田恵佑,久米佐知枝,稲尾崇,門田和也,大塚浩二郎,鈴木雄二郎,伊藤利江子,大林千穂.粘液栓の除去のみで軽快したScedosporium apiospermumによるアレルギー性気管支肺真菌症が疑われた1例. アレルギー2023;72(8):1051-1056.
• 21. 西原昂,石川秀雄.喀血. 救急医学. 2023;47(9):1074-1080.
• 22. 倉原優.コロナ禍で活躍したハイフロー酸素療法. J-IDEO. 2023;7(5):718-719.
• 23. 西原昂,石川秀雄.喀血. 救急医学. 2023;47(9):1074-1080.
• 24. 井上義一. ガイドラインから見るびまん性肺疾患診療の進歩. 肺胞蛋白症診療ガイドライン 2022.  ガイドラインから見るびまん性肺疾患診療の進歩. 肺胞蛋白症診療ガイドライン 2022. 2023;44.
• 25. 井上義一.第5回X線動態画像セミナー総評. インナービジョンP. 2023;12.
• 26. 丸岡秀一郎,松田能宣,權寧博.ストレス性呼吸器障害をめぐって. 呼吸器内科. 2023;44(2):137-138.
• 27. 松田能宣.緩和医療とストレス性呼吸障害. 呼吸器内科. 2023;44(2):174-177.
• 28. 大西幸代.結核におけるリハビリテーションの現状. 医療. 2023;77(4):275-279.
• 29. 倉原優.薬剤性咳嗽. 呼吸器内科. 2023;44(1):47-52.
• 30. 倉原優.肺非結核性抗酸菌症 治療指針が11年ぶりに改訂 主要3菌種のポイント. Medical Tribune. 2023;56(15):7.
• 31. 倉原優.急増する肺非結核性抗酸菌（NTM）症にそなえよ. J-IDEO. 2023;7(4):476-491.
• 32. 倉原優.アスペルギルス属はなぜアゾール耐性になるのか？. J-IDEO. 2023;7(4):570-581.
• 33. 倉原優.Book Review シン・感染症999の謎. J-IDEO. 2023;7(4):562.
• 34. 松田能宣.ようこそ緩和ケアの森 がん・非がん患者の呼吸器症状を診る. 2023;
• 35. 倉原優.コロナ禍で悩ましい咳をなくしたい. 医療のトリセツ: 36人の専門家が本気で考えたやさしい医療のカタチ. 2023;
• 36. 所昭宏.不眠のケア. 消化器ナーシング,特集 病態と症状をキソからおさらい! 消化器がんの緩和ケア イラストガイド ; 症状別ケア編. 2023;28(7):673-677.
• 37. 松田能宣.COPD/間質性肺疾患の呼吸困難に対する症状緩和薬物療法. 進行性疾患患者の呼吸困難の緩和に関する診療ガイドライン2023年版. 2023;86-88.
• 38. 鮫島弘睦.自然退縮を認めた肺大細胞癌の1例. 肺癌 Japanese journal of Lung Cancer. 2023;63(3):268.
• 39. 松田能宣.難治性せん妄に対する緩和ケア. がん患者の治療抵抗性の苦痛と鎮静に関する基本的な考え方の手引き2023. 2023;45-56.
• 40. 松田能宣.これからはじめる非がん患者の緩和ケア第2版. 2023;
• 41. 澄川裕充.特発性間質性肺炎 特発性肺線維症と進行性肺線維症. 臨床画像. 2023;39(5):494-501.
• 42. 倉原優.第II章. 結核、非結核性抗酸菌症. 薬剤師のための感染制御マニュアル. 2023;
• 43. 倉原優.Chapter 6「呼吸器系」. 救急外来 オススメ処方・ダメ処方. 2023;
• 44. 倉原優、木村仁、大槻登季子、嶋谷泰明、篠原莉奈、雲依美里、藤原綾子、露口一成.結核病棟におけるCOVID-19のアウトブレイク報告. 結核. 2023;98(3):79-84.
• 45. 倉原優.結核病棟におけるCOVID-19のアウトブレイク報告. 結核. 2023;98(3):78-94.
• 46. 倉原優.CASE4 COPD. medicina. 2023;60(6):824-9.
• 47. 倉原優.慢性呼吸器感染症に対する吸入抗菌薬. J-IDEO. 2023;7(3):386-387.
• 48. 倉原優.ポケット呼吸器診療2023. 2023;
• 49. 倉原優.2023年新見解に基づく肺MAC症治療とアミカシンリポソーム吸入用懸濁液. medicina. 2023;61(3):480-485.
• 50. 岡田全司,喜多洋子,露口一成.第2章In vivo遺伝子治療 第5節 感染症in vivo遺伝子治療 2．結核ワクチン. 遺伝子治療開発研究ハンドブック第2版. 2023;489-496.
• 51. 日本呼吸器学会監修.井上義一(作成委員).特発性肺線維症の治療ガイドライン2023改訂第2版. 特発性肺線維症の治療ガイドライン2023改訂第2版. 2023;

2025年1月8日掲載

2022年度英文論文

• 1. Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Suzuki K, Oyamada S, Ariyoshi K, Kihara K, Mori M. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study. Journal of Pain and Symptom Management. 2023 May;65(5):400-408.(松田能宣)
• 2. Tanizaki S, Matsumoto K, Tamiya A, Taniguchi Y, Matsuda Y, Uchida J, Ueno K, Kawachi H, Tamiya M, Yanase T, Suzuki H, Okishio K. Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 2023 Apr;503-511.(田宮朗裕)
• 3. Yasuda S,Sugano K,Matsuda Y,Kako J,Takagi Y,Watanabe H,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,Yamaguchi T. Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer. Japanese Journal of Clinical Oncology. 2023 MAR 30;53(4):327-334.(松田能宣)
• 4. Fujisawa T,Akiyama N,Morita T,Koyauchi T,Matsuda Y,Mori M,Miyashita M,Tachikawa R,Tomii K,Tomioka H,Hagimoto S,Kondoh Y,Inoue Y,Suda T. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. 2023 MAR 22;(松田能宣)
• 5. Kurahara Y,Shimatani Y. Melanoptysis. Qjm: an International Journal of Medicine. 2023 MAR 21;(倉原優)
• 6. Taniguchi Y,Tamiya A,Yanagisawa A,Shimaya M,Kawakami M,Inagaki Y,Saijo N,Matsuda Y,Okishio K. Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report. Thoracic Cancer. 2023 MAR 19;(谷口善彦)
• 7. Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Miwa S,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigat. The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study. Cancer Medicine. 2023 MAR;12(5):5397-5408.(松田能宣)
• 8. Tani Y,Kaneda H,Koh Y,Tamiya A,Isa S,Kubo A,Ogawa K,Matsumoto Y,Sawa K,Yoshimoto N,Mitsuoka S,Kawaguchi T. The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer. Clinical Lung Cancer. 2023 MAR;24(2):165-174.(伊佐俊一)
• 9. Kagawa T, Nagano H, Iwasaku M, Kawano R, Hirayama Y, Uraguchi K, Yoshioka T. Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use?: A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease. Chest. 2023 Mar;163(3):e147-e148.(香川智子)
• 10. Fujimoto D, Miura S, Tomii K, Sumikawa H, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Kijima T, Asao T, Tamiya M, Nakamura A, Yoshioka H, Tokito T, Murakami S, Tamiya A, Yokouchi H, Watanabe S, Yamaguchi O, Morinaga R, Jodai T, Ito K, Shiraishi Y, Kogure Y, Shibaki R, Yamamoto N. Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer. Sci Rep. 2023 Mar;13(1):3698.(澄川裕充)
• 11. Akihiro Tamiya, Motohiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Takahisa Kawamura, Kei Kunimasa, Takako Inoue, Kazumi Nishino, Kyoichi Okishio. Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting. Anticancer Research. 2023 Mar;43(3):1325-1330.(田宮朗裕)
• 12. Abe A, Fujisawa D, Miyajima K, Takeuchi E, Takeuchi M, Mimura M, Imai K, Uemura K, Watanabe H, Matsuo N, Matsuda Y, Maeda I, Ogawa A, Yoshiuchi K, Iwase S. Influence of dosing pattern of antipsychotics on treatment outcome of delirium in patients with advanced cancer. Japanese Journal of Clinical Oncology. 2023 Mar;53(4):321-326.(松田能宣)
• 13. Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue. Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation. Journal of Thoracic Disease. 2023 Feb;15(2):300-310.(新井徹)
• 14. Takeuchi S,Kubota K,Sugawara S,Teramukai S,Noro R,Fujikawa K,Hirose T,Atagi S,Minami S,Iida S,Kuraishi H,Aiba T,Minegishi Y,Matsumoto M,Seike M,Gemma A,Kawahara M,Japan-Multinational Trial Org JMTO. Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01). Cancer Medicine. 2023 FEB 21;(安宅信二)
• 15. Kurahara Y, Nagayama I. Bilothorax. New England Journal of Medicine. 2023 Feb;388(7):e17.(倉原優)
• 16. Hamamoto Y,Kawamura M,Uchida H,Takagahara K,Katori C,Asai H,Harada H,Shimizu S,Morii E,Yoshida K. Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases. Applied Immunohistochemistry & Molecular Morphology. 2023 FEB;31(2):107-112.(清水重喜)
• 17. Ogura T,Inoue Y,Azuma A,Homma S,Kondoh Y,Tanaka K,Ochiai K,Sugiyama Y,Nukiwa T. Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan. Advances in therapy. 2023 JAN 24;(井上義一)
• 18. Osaki M,Arai T,Sumikawa H,Takimoto T,Takeuchi N,Tamiya A,Okishio K,Inoue Y. Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis. Oncology. 2023 JAN 23;(大﨑恵)
• 19. Imai K, Morita T, Mori M, Kiuchi D, Yokomichi N, Miwa S, Okamoto S, Yamauchi T, Naito AS, Matsuda Y, Maeda I, Sugano K, Ikenaga M, Inoue S, Satomi E. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. Journal of Pain and Symptom Management. 2023 Jan;(松田能宣)
• 20. K. Kojima;H Yoon; K. Okishio; K. Tsuyuguchi. Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease. Scientific Reports. 2023 1;131012.(小島健介)
• 21. Suzukawa M, Ohta K, Hashimoto H, Oyamada Y, Miki M, Ogawara M, Inoue Y, Saito AM, Fukutomi Y, Kobayashi N, Taniguchi M, NHOM- Asthma Study Group. Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. doi: 10.1016/j.anai.2023.01.003.(井上義一)
• 22. Inoue Y,Wells AU,Song JW,Xu ZJ,Kitamura H,Suda T,Okamoto M,Muller H,Coeck C,Rohr KB,Kolb M,Brown KK. Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial. Respirology. 2023 JAN 15;(井上義一)
• 23. Moda M,Arai T,Takeuchi N,Kagawa T,Takimoto T,Sumikawa H,Shimizu S,Inoue Y. Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration. Internal Medicine. 2023;62(4):577-582.(茂田光弘)
• 24. Okuda R,Ogura T,Hisata S,Baba T,Kondoh Y,Suda T,Johkoh T,Iwasawa T,Tomioka H,Bando M,Azuma A,Inoue Y,Arai T,Nakamura Y,Miyamoto A,Miyazaki Y,Chiba H,Ishii H,Hamada N,Terasaki Y,Kuwahira I,Sato S,Kato S,Suzuki T,Sakamoto S,Nishioka Y,Hattori N,Hashimoto N,Morita S,Ichihara N,Miyata H,Hagiwara K,Nukiwa T,Kobayashi K. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry. Respiratory Investigation. 2023 JAN;61(1):95-102.(井上義一)
• 25. Imaji M, Fujimoto D, Sato Y, Sakata Y, Oya Y, Tamiya M, Suzuki H, Ikeda H, Kijima T, Matsumoto H, Kanazu M, Hino A, Inaba M, Tsukita Y, Arai D, Maruyama H, Hara S, Tsumura S, Kobe H, Sumikawa H, Sakata S, Yamamoto N. Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study. Eur J Cancer. 2023 Jan;17915-24.(澄川裕充)
• 26. Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M. Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study). Allergology International. 2023 Jan;72(1):63-74.(井上義一)
• 27. Hiroyuki Otani, Amano K, Morita T, Miura T, Mori N, Tatara R, Kessoku T, Matsuda Y, Tagami K, Mori M, Taniyama T, Nakajima N, Nakanishi E, Kako J, Shirado AN, Yokomichi N, Miyashita M. Impact of taste/smell disturbances on dietary intakes and cachexia-related quality of life in patients with advanced cancer. Support Care Cancer. 2023 Jan;31(2):141.(松田能宣)
• 28. Oda M, YamauramK, Ishii H, Kitamura N, Tazawa R, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Tanaka T, Takada T, Nonaka H, Nakata K. Quantitative Evaluation of Changes in Three-Dimensional CT Density Distributions in Pulmonary Alveolar Proteinosis after GM-CSF Inhalation. Respiration. 2023;102(2):101-109.(井上義一)
• 29. Moda M,Suga M,Kasai S,Okochi Y,Yoshimura N,Fukata M,Tokuda H. Incidence, Characteristics, Clinical Course, and Risk Factors of Ulcerative Colitis-related Lung Diseases. Chest. 2022 DEC;162(6):1310-1323.(茂田光弘)
• 30. Nagata K,Horie T,Chohnabayashi N,Jinta T,Tsugitomi R,Shiraki A,Tokioka F,Kadowaki T,Watanabe A,Fukui M,Kitajima T,Sato S,Tsuda T,Kishimoto N,Kita H,Mori Y,Nakayama M,Takahashi K,Tsuboi T,Yoshida M,Hataji O,Fuke S,Kagajo M,Nishine H,Kobayashi H,Nakamura H,Okuda M,Tachibana S,Takata S,Osoreda H,Minami K,Nishimura T,Ishida T,Terada J,Takeuchi N,Kohashi Y,Inoue H,Nakagawa Y,Kikuchi T,Tomii K,FLOCOP Study Investigators. Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD. American Journal of Respiratory and Critical Care Medicine. 2022 DEC 1;206(11):1326-1335.(竹内奈緒子)
• 31. Takeuchi N,Arai T,Sasaki Y,Akira M,Matsuda Y,Tachibana K,Kasai T,Inoue Y. Predictive factors for relapse in corticosteroid-treated patients with chronic eosinophilic pneumonia. Journal of Thoracic Disease. 2022 NOV 29;14(11):4352-4360.(竹内奈緒子)
• 32. Amano K,Morita T,Miura T,Mori N,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Ishiki H,Matsuoka H,Satomi E,Hopkinson JB,Baracos VE,Miyashita M. Development and validation of questionnaires for eating-related distress among advanced cancer patients and families. Journal of Cachexia、Sarcopenia and Muscle. 2022 NOV 20;(松田能宣)
• 33. Taniguchi Y,Matsuda Y,Mori M,Ito M,Ikari T,Tokoro A,Aiki S,Hoshino S,Kiuchi D,Suzuki K,Igarashi Y,Odagiri T,Oya K,Kubo E,Yamaguchi T. Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study. Translational Lung Cancer Research. 2022 NOV 12;(谷口善彦)
• 34. Sato K,Akamatsu H,Koh Y,Ogawa K,Isa SI,Ando M,Tamiya A,Kubo A,Kitagawa C,Kawaguchi T,Yamamoto N. Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes. BMC Cancer. 2022 NOV 8;22(1):(伊佐俊一)
• 35. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Tamiya A,Nosaki K,Fukumitsu K,Akechi T. Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study. Oncologist. 2022 NOV 3;27(11):982-990.(松田能宣)
• 36. Sato Y,Sumikawa H,Shibaki R,Morimoto T,Sakata Y,Oya Y,Tamiya M,Suzuki H,Matsumoto H,Yokoi T,Hashimoto K,Kobe H,Hino A,Inaba M,Tsukita Y,Ikeda H,Arai D,Maruyama H,Hara S,Tsumura S,Sakata S,Fujimoto D. Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer A Real-World Setting. Chest. 2022 NOV;162(5):1188-1198.(澄川裕充)
• 37. Yoshida S,Tsuyuguchi K,Kobayashi T,Shimatani Y,Inoue Y. Effect of sputum quality on Mycobacterium avium-intracellulare complex lung disease diagnosis and treatment initiation according to disease type. Diagnostic Microbiology and Infectious Disease. 2022 NOV;104(3):(吉田志緒美)
• 38. Ogura T,Suda T,Inase N,Nishioka Y,Azuma A,Okamoto M,Takizawa A,Ito T,Rohr KB,Inoue Y. Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial. Respiratory Investigation. 2022 NOV;60(6):787-797.(井上義一)
• 39. Yamada A,Kagawa T,Nishimoto Y,Sugawara R,Arai T,Inoue Y,Taiji R,Okada H,Takewa M,Sugimura H,Tanaka T. Exogenous Lipoid Pneumonia Caused by Gargling With Sesame Oil A Case Report. Journal of Thoracic Imaging. 2022 NOV;37(6):W97-W100.(香川智子)
• 40. Akiyama N,Fujisawa T,Morita T,Koyauchi T,Matsuda Y,Mori M,Miyashita M,Tachikawa R,Tomii K,Tomioka H,Hagimoto S,Kondoh Y,Inoue Y,Suda T. End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation. Respiratory Research. 2022 OCT 29;23(1):(松田能宣)
• 41. Takimoto T. Corticosteroids for pulmonary lymphangitic carcinomatosis. BMJ Supportive and Palliative Care. 2022 OCT 27;(滝本宜之)
• 42. Kojima K,Imai S,Samejima H,Fujiwara A,Tokunaga T,Yoon H,Okishio K. PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC Cancer. 2022 OCT 15;22(1):(小島健介)
• 43. Sa-ngiamwibool P,Hamasaki M,Kinoshita Y,Matsumoto S,Sato A,Tsujimura T,Kasai T,Hiroshima K,Kushitani K,Takeshima Y,Kawahara K,Iwasaki A,Nabeshima K. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features. Annals of Diagnostic Pathology. 2022 OCT;60(笠井孝彦)
• 44. Kurahara Y, Matsuda Y, Tsuyuguchi K, Tokoro A. Delirium in Patients with COVID-19 in Japan. Internal Medicine. 2022 Oct;61(19):2861-2866.(倉原優)
• 45. Matsuda Y,Morita T,Oya K,Tagami K,Naito AS,Kashiwagi H,Otani H. Drug Choice for Hyperactive Delirium in Terminally-Ill Cancer Patients: A Nationwide Survey. Journal of Pain and Symptom Management. 2022 OCT;64(4):E231-E234.(松田能宣)
• 46. Takimoto T, Kobayashi T, Minomo S. Concomitant Recurrent Pneumothorax and Takotsubo Cardiomyopathy in a Chronic Obstructive Pulmonary Disease Patient. Cureus Journal of Medical Science. 2022 Oct;14(10):e30850.(滝本宜之)
• 47. Marinescu DC,Raghu G,Remy-Jardin M,Travis WD,Adegunsoye A,Beasley MB,Chung JH,Churg A,Cottin V,Egashira R,Perez ERF,Inoue Y,Johannson KA,Kazerooni EA,Khor YH,Lynch DA,Muller NL,Myers JL,Nicholson AG,Rajan S,Saito-Koyama R,Troy L,Walsh SLF,Wells AU,Wijsenbeek MS,Wright JL,Ryerson CJ. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis. Chest. 2022 SEP;162(3):614-629.(井上義一)
• 48. Takimoto T,Nakamura Y. Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis. Diseases. 2022 SEP;10(3):(滝本宜之)
• 49. Tanaka M,Fujimoto D,Akamatsu H,Sumikawa H,Yamamoto N. Radiographic findings useful for diagnosis of primary chest wall lymphoma without preceding pleural disease: A case report. Respirology Case Reports. 2022 SEP;10(9):(澄川裕充)
• 50. Nishioka Y,Toyoda Y,Egashira R,Johkoh T,Terasaki Y,Hebisawa A,Abe K,Baba T,Fujikura Y,Fujita E,Hamada N,Handa T,Hasegawa Y,Hidaka K,Hisada T,Hisata S,Honjo C,Ichikado K,Inoue Y,Izumi S,Kato M,Kishimoto T,Okamoto M,Miki K,Mineshita M,Nakamura Y,Sakamoto S,Sano M,Tsukada Y,Yamasue M,Bando Y,Homma S,Hagiwara K,Suda T,Inase N. Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype. BMJ Open Respiratory Research. 2022 SEP;9(1):(井上義一)
• 51. Kako J,Kobayashi M,Kanno Y,Kajiwara K,Nakano K,Morikawa M,Matsuda Y,Shimizu Y,Hori M,Niino M,Suzuki M,Shimazu T. Nursing support for symptoms in patients with cancer and caregiver burdens: a scoping review protocol. BMJ Open. 2022 SEP;12(9):(松田能宣)
• 52. Kurahara Y. Fibrothorax in a Patient with Social Withdrawal. Internal Medicine. 2022;doi: 10.2169/internalmedicine.0333-22.(倉原優)
• 53. Cottin V,Selman M,Inoue Y,Wong AW,Corte TJ,Flaherty KR,Han MK,Jacob J,Johannson KA,Kitaichi M,Lee JS,Agusti A,Antoniou KM,Bianchi P,Caro F,Florenzano M,Galvin L,Iwasawa T,Martinez FJ,Morgan RL,Myers JL,Nicholson AG,Occhipinti M,Poletti V,Salisbury ML,Sin DD,Sverzellati N,Tonia T,Valenzuela C,Ryerson CJ,Wells AU,Amer Thoracic Soc,European Resp Soc,Japanese Resp Soc,Assoc Latinoamer Torax. Syndrome of Combined Pulmonary Fibrosis and Emphysema An Official ATS/ERS/JRS/ALAT Research Statement. American Journal of Respiratory and Critical Care Medicine. 2022 AUG 15;206(4):E7-E41.(井上義一)
• 54. Kurahara Y. Diabetic foot ulcer infection with Mycobacterium avium. Qjm: an International Journal of Medicine. 2022 AUG 13;115(8):540-540.(倉原優)
• 55. Kurahara Y. Cryptococcal pericarditis. Qjm: an International Journal of Medicine. 2022 AUG 13;115(8):541-542.(倉原優)
• 56. Matsuda Y,Morita T,Oya K,Tagami K,Naito AS,Kashiwagi H,Otani H. Current practice of pharmacological treatment for hyperactive delirium in terminally ill cancer patients: results of a nationwide survey of Japanese palliative care physicians and liaison psychiatrists. Japanese Journal of Clinical Oncology. 2022 AUG 5;52(8):897-902.(松田能宣)
• 57. Abe A,Amano K,Morita T,Miura T,Mori N,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Kiuchi D,Ishiki H,Matsuoka H,Satomi E,Miyashita M. Beliefs and Perceptions About Parenteral Nutrition and Hydration by Advanced Cancer Patients. Palliative Medicine Reports. 2022 AUG 1;3(1):132-139.(松田能宣)
• 58. Oya K, Morita T, Tagami K, Matsuda Y, Naito AS, Kashiwagi H, Otani H. Physicians' Beliefs and Attitudes Toward Hypoactive Delirium in The Last Days of Life. Journal of Pain and Symptom Management. 2022 Aug;64(2):110-118.(松田能宣)
• 59. Matsuda Y,Hasuo H,Narita K,Matsuoka H,Morita R,Kiuchi D,Ikari T,Hori T,Okazaki K,Sakai K,Aiki S,Okabayashi H,Oyamada S,Ariyoshi K,Tokoro A,Fukunaga M. Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study. BMJ Supportive and Palliative Care. 2022 JUL 19;(松田能宣)
• 60. Matsumoto Y,Kawaguchi T,Watanabe M,Isa S,Ando M,Tamiya A,Kubo A,Kitagawa C,Yoshimoto N,Koh Y. Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer. BMC Cancer. 2022 JUL 15;22(1):(伊佐俊一)
• 61. Matsugi A,Nishishita S,Yoshida N,Tanaka H,Douchi S,Bando K,Tsujimoto K,Honda T,Kikuchi Y,Shimizu Y,Odagaki M,Nakano H,Okada Y,Mori N,Hosomi K,Saitoh Y. Impact of Repetitive Transcranial Magnetic Stimulation to the Cerebellum on Performance of a Ballistic Targeting Movement. Cerebellum. 2022 JUL 4;(堂地晋弥)
• 62. Arai T,Inoue Y. Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist. ERJ Open Research. 2022 JUL 1;8(3):(新井徹)
• 63. Asami K,Ando M,Nishimura T,Yokoi T,Tamura A,Minato K,Mori M,Ogushi F,Yamamoto A,Yoshioka H,Kawahara M,Atagi S. A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non-small cell lung cancer harboring EGFR mutations (JMTO LC12-01). Thorac Cancer. 2022 JUN;13(12):1827-1836.(安宅信二)
• 64. Tanaka-Yagi Y,Yamaguchi T,Matsuda Y,Mori M,Ikari T,Miwa S,Suzuki K,Tachikawa R,Nakata K,Kanatani M. Morphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report. Indian Journal of Palliative Care. 2022 APR-JUN;28(2):221-223.(松田能宣)
• 65. Raghu G,Remy-Jardin M,Richeldi L,Thomson CC,Inoue Y,Johkoh T,Kreuter M,Lynch DA,Maher TM,Martinez FJ,Molina-Molina M,Myers JL,Nicholson AG,Ryerson CJ,Strek ME,Troy LK,Wijsenbeek M,Mammen MJ,Hossain T,Bissell BD,Herman DD,Hon SM,Kheir F,Khor YH,Macrea M,Antoniou KM,Bouros D,Buendia-Roldan I,Caro F,Crestani B,Ho L,Morisset J,Olson AL,Podolanczuk A,Poletti V,Selman M,Ewing T,Jones S,Knight SL,Ghazipura M,Wilson KC,Amer Thoracic Soc,European Resp Soc,Japanese Resp Soc,Assoc Latinoamer Torax. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2022 MAY 1;205(9):E18-E47.(井上義一)
• 66. Kurahara Y, Kobayashi T, Tachibana K, Tsuyuguchi K. The feasibility of rifampicin Re-administration in patients with tuberculosis and Clostridioides difficile infection. Journal of Infection and Chemotherapy. 2022 Apr;28(4):558-562.(倉原優)
• 67. Kako J, Kobayashi M, Kajiwara K, Kimura Y, Oosono Y, Takegata M, Nakano K, Matsuda Y, Nakamura N, Kawashima N, Hirano Y, Kitae M, Yamaguchi K, Iwamoto H, Hattori N, Sawatari H, Shiono S, Ogino H, Nishioka Y, Amano K, Yorke J. Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients With Lung Cancer. Journal of Pain and Symptom Management. 2022 Aug;64(2):e83-e89.(松田能宣)
• 68. Toru Arai, Masaki Hirose, Yoshimasa Hamano, Tomoko Kagawa, Akihiro Murakami, Hiroshi Kida, Atsushi Kumanogoh, Yoshikazu Inoue. Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis. Canadian Respiratory Journal. 2022 Mar;22(新井徹)
• 69. Corina N D'Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, Masaaki Toda, Ahmed M Abdel-Hamid, Hajime Fujimoto, Osamu Hataji, Hiroki Nakahara, Atsuro Takeshita, Kota Nishihama, Tomohito Okano, Haruko Saiki, Yuko Okano, Atsushi Tomaru, Valeria Fridman D'Alessandro, Miyako Shiraishi, Akira Mizoguchi, Ryoichi Ono, Junpei Ohtsuka, Masayuki Fukumura, Tetsuya Nosaka, Xuenan Mi, Diwakar Shukla, Kensuke Kataoka, Yasuhiro Kondoh, Masaki Hirose, Toru Arai, Yoshikazu Inoue, Yutaka Yano, Roderick I Mackie , Isaac Cann, Esteban C Gabazza. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis. Nature Communication. 2022 Mar;13(1):1558-1580.(広瀬雅樹)
• 70. Matsuda Y, Kosugi T, Yamanaka M, Fukumori T, Inoue A, Horiki M, Matsunuma R, Kataoka Y, Kitamura H, Kataoka K, Matsuoka H, Tokoro A, Inoue Y. Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseases. Respiratory Investigation. 2022 Mar;60(2):309-317.(松田能宣)
• 71. Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue. Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis. Journal of Thoracic Disease. 2022 Feb;14(2):78-294.(新井徹)

和文原著・著書等

• 1. 井上義一. リンパ脈管筋腫(LAM)症診療の手引き2022. リンパ脈管筋腫(LAM)症診療の手引き2022. 2023;
• 2. 井上義一. 8 リンパ脈管筋腫症. 呼吸器疾患最新の治療2023-2024. 2023;329-331.
• 3. 松田能宣. 各論 疾患別にみた実践！心療内科的診療術 2気管支喘息. そのとき心療内科医のならこう考える かかりつけ医でもできる！心療内科的診療術. 2023;
• 4. 蓮尾英明, 松岡弘道, 松田能宣. がん患者の呼吸困難・痛み・精神症状を診るロジック−知っていればこんなに使える非薬物療法アプローチ！ 薬物療法が本当に有効な病態を見抜く！※書籍. がん患者の呼吸困難・痛み・精神症状を診るロジック−知っていればこんなに使える非薬物療法アプローチ！ 薬物療法が本当に有効な病態を見抜く！. 2023;
• 5. 倉原優. COVID-19と細菌性肺炎の合併. 治療. 2023;105306-11.
• 6. 滝本宜之. リンパ脈管筋腫症. 今日の治療指針. 2023;320-321.
• 7. 井上義一. リンパ脈管筋腫症. 最新ガイドラインに基づく呼吸器疾患診療指針2023-24. 2022;437-445.
• 8. 倉原優, 露口一成. 内視鏡下に声帯炎を観察しえたアミカシン硫酸塩吸入用製剤による失声の2例. Kekkaku. 2022;97(7):381-5.
• 9. 井上義一. 肺胞蛋白症（PAP). 間質性肺炎のみかた、考え方. 2022;127-134.
• 10. 井上義一. リンパ脈管筋腫症（LAM). 間質性肺炎のみかた、考え方. 2022;135-142.
• 11. 倉原優. 日常診療に潜む「処方カスケード」. 咳嗽. 総合診療. 2022;32(10):1205-1208.
• 12. 松田能宣. 【日常診療に潜む「処方カスケード」-その症状、薬のせいではないですか?】抑うつ 抗うつ薬を使う前に、こちらの薬をチェックせよ!(解説). 総合診療. 2022;32(10):1192-1195.
• 13. 倉原優, 東崇皓, 川﨑咲姫, 安井みのり, 岸本歩, 新谷亮多, 小林岳彦, 橘和延, 露口一成. アミカシン硫酸塩吸入用製剤（販売名アリケイス吸入液590mg）導入における医薬連携および調剤薬局へのアンケート調査. Kekkaku. 2022;97(6):353-60.
• 14. 井上義一. 特発性肺線維症の新規薬剤治験. 月刊雑誌 呼吸器内科. 2022;42339-343.
• 15. 岸本歩、赤井裕子、門野恵莉、中田華. 重症心身障害児・者病棟入院患者におけるポリファーマシーとその要因解析－長期服用漢方六君子湯の適正使用－. 漢方と最新治療. 2022;31(3):159-163.
• 16. 松田能宣. 【呼吸器疾患の緩和ケアを考える】非がん性呼吸器疾患の呼吸困難に対する薬物療法(解説). 呼吸器内科. 2022;42(2):142-145.
• 17. 吉田志緒美. 【医学細菌・真菌の分類と菌種の最新情報Up-to-Date ―注目すべき菌種を含めて】抗酸菌―近年,変更された菌種/新種を中心として. 臨床と微生物 49(4);333-341,2022. 2022;49(4):333-341.
• 18. 井上義一広瀬雅樹滝本宜之, 新井徹. リンパ脈管筋腫症. 日本臨床. 2022;80-増刊号6599-607.
• 19. 角甲純(兵庫県立大学看護学部), 中村陽一, 西智弘, 高木雄亮, 松田能宣, 渡邊紘章, 笠原庸子, 合屋将, 小原弘之, 森雅紀, 山口崇. 呼吸困難を有する慢性進行性疾患患者に対する送風療法の有効性 システマティックレビュー・メタ解析(原著論文). Palliative Care Research. 2022;17(1):33-42.
• 20. 倉原優. COPDと気管支喘息,その周辺疾患. 生物学的製剤TSLPモノクローナル抗体. 日本臨床増刊号・共著. 2022;468-472.
• 21. 倉原優. 総合診療外来に実装したい最新エビデンス My Best 3. 喘息. 総合診療. 2022;32(6):716-719.
• 22. 日本呼吸器学会肺胞蛋白症診療ガイドライン2022作成委員会. 肺胞蛋白症診療ガイドライン2022. 肺胞蛋白症診療ガイドライン2022. 2022;
• 23. 松田能宣. 【すっきりしない症状 まれな症状の緩和ケア-どこまでやったら合格か?】(第II章)すっきりしない呼吸器症状 パニック(不安発作)と同時にくる息苦しさ(解説). 緩和ケア. 2022;32(6月増刊):078-083.
• 24. 清水重喜、蓑毛祥次郎. 気管支拡張症. 非腫瘍性疾患病理アトラス. 2022;p198-203..
• 25. 清水重喜、前島亜希子、桂義久、杉野弘和、本間浩一、松野吉宏、河端美則. 寄生虫による肺病変. 非腫瘍性疾患病理アトラス. 2022;p361-366.
• 26. 清水重喜、岡元昌樹、富永正樹. コラム インジウム肺. 非腫瘍性疾患病理アトラス. 2022;p376..
• 27. 武田麻衣子、清水重喜、吉田恭太郎、大林千穂. 結核症および非結核性抗酸菌症. 非腫瘍性疾患病理アトラス. 2022;p316-323.
• 28. 清水重喜. リンパ性間質を伴う小結節性胸腺腫、化生性胸腺腫、脂肪線維腺腫、いわゆる顕微鏡的胸腺腫といわゆる硬化性胸腺腫. 腫瘍病理鑑別診断アトラス縦隔腫瘍・胸膜腫瘍第二版. 2022;P31-39.
• 29. 清水重喜. 胸膜生検、細胞診セルブロック. 腫瘍病理鑑別診断アトラス縦隔腫瘍・胸膜腫瘍第二版. 2022;P197-205.
• 30. 冨岡洋海, 宮崎泰成, 井上義一, 江頭玲子, 河村哲治, 佐野博幸, 上甲剛, 武村民子, 久田剛志, 福岡順也. 過敏性肺炎診療指針 2022. 過敏性肺炎診療指針 2022. 2022;
• 31. 倉原優. ポケット呼吸器診療2022. シーニュ・著書. 2022;
• 32. 倉原優. コロナ禍とアフターコロナを見据えての咳診療のあり方. 治療. 2022;104392-395.
• 33. 倉原優. 副鼻腔気管支症候群と上気道咳症候群の周辺. 治療. 2022;104475-478.
• 34. 吉田志緒美. 抗酸菌検査における培養条件の工夫の重要性. 「検査と技術」 臨床検査のピットフォール 50(4), 460-464, 2022 . 2022;50(4):460-464.
• 35. 松田能宣, 井上義一. 【マイナーエマージェンシー 外来診療・一人当直に強くなる!いざというときの対処法】内科的minor emergency 過換気症候群(解説). Medical Practice. 2022;39(臨増):91-92.

2025年1月8日掲載

2021年度英文論文

• 1. Tamiya M, Fujikawa K, Suzuki H, Yokoyama T, Uenami T, Tamiya A, Sato Y, Saito G, Uchida J, Morita M, Hirashima T, Fukuda Y, Kanazu M, Hosoya K, Suzuki T, Ueno K, Fujimoto D, Kumagai T, Teramukai S. Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002. INVESTIGATIONAL NEW DRUGS. 2022 4;40(2):361-369.(田宮朗裕)
• 2. Matsunuma R, Yamaguchi T, Mori M, Ikari T, Suzuki K, Matsuda Y, Matsumoto Y, Watanabe H, Amano K, Kamura R, Kizawa Y. Predictive Factors for the Development of Dyspnea Within 7 Days After Admission Among Terminally Ill Cancer Patients. AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE. 2022 4;39(4):413-420.(松田能宣)
• 3. Brown KK, Inoue Y, Flaherty KR, Martinez FJ, Cottin V, Bonella F, Cerri S, Danoff SK, Jouneau S, Goeldner RG, Schmidt M, Stowasser S, Schlenker-Herceg R, Wells AU. Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases. RESPIROLOGY. 2022 4;27(4):294-300.(井上義一)
• 4. Flaherty KR, Wells AU, Cottin V, Devaraj A, Inoue Y, Richeldi L, Walsh SLF, Kolb M, Koschel D, Moua T, Stowasser S, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD trial investigators. Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. EUROPEAN RESPIRATORY JOURNAL. 2022 3;59(3):2004538.(井上義一)
• 5. Kinnosuke Matsumoto, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Yoshinobu Matsuda, Hayato Kawachi, Motohiro Tamiya, Satoshi Tanizaki, Junji Uchida, Kiyonobu Ueno, Takafumi Yanase, Hidekazu Suzuki, Shinji Atagi. Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study. JOURNAL OF GERIATRIC ONCOLOGY. 2022 3;13(2):207-213.(田宮朗裕)
• 6. Matsuda Y, Kosugi T, Yamanaka M, Fukumori T, Inoue A, Horiki M, Matsunuma R, Kataoka Y, Kitamura H, Kataoka K, Matsuoka H, Tokoro A, Inoue Y. Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseases. RESPIRATORY INVESTIGATION. 2022 3;60(2):309-317.(松田能宣)
• 7. Matsuda Y, Yamaguchi T, Matsumoto Y, Ishiki H, Usui Y, Kako J, Suzuki K, Matsunuma R, Mori M, Watanabe H, Zenda S. Research policy in supportive care and palliative care for cancer dyspnea. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2022 3;52(3):260-265.(松田能宣)
• 8. K. Kojima; T. Sakamoto; T. Kasai; H. Yoon; S. Atagi. A quantitative evaluation of the histological type dependence of the programmed death-ligand 1 expression in non-small cell lung cancer including various adenocarcinoma subtypes: a cross-sectional study. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2022 3;52(3):281-285.(小島健介)
• 9. Swigris JJ, Bushnell DM, Rohr K, Mueller H, Baldwin M, Inoue Y. Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases. BMJ OPEN RESPIRATORY RESEARCH. 2022 3;9(1):e001167.(井上義一)
• 10. Fujimoto D, Akamatsu H, Morimoto T, Wakuda K, Sato Y, Kawa Y, Yokoyama T, Tamiya M, Hiraoka R, Shingu N, Ikeda H, Tamiya A, Kanazu M, Miyauchi E, Miura S, Yanai M, Yomota M, Morinaga R, Yokoi T, Hata A, Suzuki H, Matsumoto H, Sakata S, Furuya N, Harutani Y, Nakachi I, Otsuki A, Uematsu S, Hara S, Yokoo K, Sugimoto T, Yamamoto N. Histologic transformation of epidermal growth factor receptor-mutated lung cancer. EUROPEAN JOURNAL OF CANCER. 2022 3;16641-50.(田宮朗裕)
• 11. Satoshi Ishikawa, Yuriko Ozeki, Satomi Suga, Yasuhiko Mukai, Haruka Kobayashi, Erina Inouchi, Shaban A Kaboso, Gebremichal Gebretsadik, Desak Nyoman Surya Suameitria Dewi, Akihito Nishiyama, Yoshitaka Tateishi, Hayato Takihara, Shujiro Okuda, Shiomi Yoshida, Naoaki Misawa, Sohkichi Matsumoto. Monitoring IgG against Mycobacterium tuberculosis proteins in an Asian elephant cured of tuberculosis that developed from long-term latency. SCIENTIFIC REPORTS. 2022 3;12(1):4310.(吉田志緒美)
• 12. Futami Y, Takeda Y, Koba T, Narumi R, Nojima Y, Ito M, Nakayama M, Ishida M, Yoshimura H, Naito Y, Fukushima K, Takimoto T, Edahiro R, Matsuki T, Nojima S, Hirata H, Koyama S, Iwahori K, Nagatomo I, Shirai Y, Suga Y, Satoh S, Futami S, Miyake K, Shiroyama T, Inoue Y, Adachi J, Tomonaga T, Ueda K, Kumanogoh A. CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis by proteomics of serum extracellular vesicles. INTERNATIONAL IMMUNOLOGY. 2022 3;dxac009.(滝本宜之)
• 13. Corina N D'Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, Masaaki Toda, Ahmed M Abdel-Hamid, Hajime Fujimoto, Osamu Hataji, Hiroki Nakahara, Atsuro Takeshita, Kota Nishihama, Tomohito Okano, Haruko Saiki, Yuko Okano, Atsushi Tomaru, Valeria Fridman D'Alessandro, Miyako Shiraishi, Akira Mizoguchi, Ryoichi Ono, Junpei Ohtsuka, Masayuki Fukumura, Tetsuya Nosaka, Xuenan Mi, Diwakar Shukla, Kensuke Kataoka, Yasuhiro Kondoh, Masaki Hirose, Toru Arai, Yoshikazu Inoue, Yutaka Yano, Roderick I Mackie, Isaac Cann, Esteban C Gabazza. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis. NATURE COMMUNICATIONS. 2022 3;13(1):1558.(広瀬雅樹)
• 14. Cottin V, Tomassetti S, Valenzuela C, Walsh S, Antoniou K, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty K, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins G, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers J, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi L, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson C. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. American journal of respiratory and critical care medicine. 2022 3;(井上義一)
• 15. Otsubo K, Kishimoto J, Ando M, Kenmotsu H, Minegishi Y, Horinouchi H, Kato T, Ichihara E, Kondo M, Atagi S, Tamiya M, Ikeda S, Harada T, Takemoto S, Hayashi H, Nakatomi K, Kimura Y, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakagawa K, Nakanishi Y, Okamoto I. Nintedanib plus chemotherapy for non-small cell lung cancer with IPF: a randomized phase 3 trial. The European respiratory journal. 2022 3;2200380.(安宅信二)
• 16. Arai T; Hirose M, Hamano Y, Kagawa T, Murakami A, Kida H, Kumanogoh A, Inoue Y. Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis. Canadian respiratory journal. 2022 3;2022(1):1107673.(新井徹)
• 17. Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. THORAX. 2022 2;77(2):143-153.(井上義一)
• 18. Sakamoto R, Ohtake Y, Kataoka Y, Matsuda Y, Hata T, Otonari J, Yamane A, Matsuoka H, Yoshiuchi K. Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta-analysis.JOURNAL OF DIABETES INVESTIGATION. 2022 2;12(3):262-270.(松田能宣)
• 19. Langford B, Diamantopoulos A, Maher TM, Inoue Y, Rohr KB, Baldwin M. Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework. ADVANCES IN THERAPY. 2022 2;39(2):1045-1054.(井上義一)
• 20. Murakami Y, Tamiya A, Taniguchi Y, Adachi Y, Enomoto T, Azuma K, Inagaki Y, Kouno S, Matsuda Y, Okishio K, Atagi S. Retrospective analysis of long-term survival factors in patients with advanced non-small cell lung cancer treated with nivolumab. THORACIC CANCER. 2022 2;13(4):593-601.(田宮朗裕)
• 21. Okuma Y, Shimokawa M, Hashimoto K, Mizutani H, Wakui H, Murakami S, Atagi S, Minato K, Seike M, Ohe Y, Kubota K; Tokyo Cooperative Oncology Group. Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901). FUTURE ONCOLOGY. 2022 2;18(5):523-531.(安宅信二)
• 22. Matsuoka H, Clark K, Fazekas B, Oyamada S, Brown L, Ishiki H, Matsuda Y, Hasuo H, Ariyoshi K, Lee J, Le B, Allcroft P, Kochovska S, Fujiwara N, Miyaji T, Lovell M, Agar M, Yamaguchi T, Satomi E, Iwase S, Phillips J, Koyama A, Currow DC. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. BMJ OPEN. 2022 2;12(2):(松田能宣)
• 23. Kanako Katayama, Toru Arai, Takehiko Kobayashi, Sayoko Shintani, Naoko Takeuchi, Yoshinobu Matsuda, Chikatoshi Sugimoto, Yasushi Inoue, Maiko Takeda, Takahiko Kasai, Masanori Akira, Yoshikazu Inoue. Pleuroparenchymal Fibroelastosis with a Predominantly Airway-centered Distribution: A Late Complication of Chemotherapy. INTERNAL MEDICINE. 2022 2;61(4):7402-21.(片山加奈子)
• 24. Enomoto T, Tamiya A, Matsumoto K, Adachi Y, Azuma K, Inagaki Y, Kouno S, Taniguchi Y, Saijo N, Okishio K, Atagi S. Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 2022 2;(田宮朗裕)
• 25. Naito T, Uchino J, Kojima T, Matano Y, Minato K, Tanaka K, Mizukami T, Atagi S, Higashiguchi T, Muro K, Takayama K, Furuse J, Morishima E, Takiguchi T, Tamura K. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index. CANCER. 2022 2;(安宅信二)
• 26. Yu Kurahara, Yoshinobu Matsuda, Kazunari Tsuyuguchi, Akihiro Tokoro. Delirium in Patients with COVID-19 in Japan. Internal medicine (Tokyo, Japan). 2022 2;10(2169):9013-21.(倉原優)
• 27. Arai T, Hirose M, Kagawa T, Hatsuda K, Inoue Y. Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis. JOURNAL OF THORACIC DISEASE. 2022 2;14(2):278-294.(新井徹)
• 28. Hiroko Kitaoka, Takayuki Takimoto, Takashi Kijima. Static end-tidal expiratory computed tomography visualizes only a static type of expiratory central airway collapse. RESPIRATORY INVESTIGATION. 2022 1;60(1):182-183.(滝本宜之)
• 29. Lancaster L, Bonella F, Inoue Y, Cottin V, Siddall J, Small M, Langley J. Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden. RESPIROLOGY. 2022 1;27(1):66-75.(井上義一)
• 30. Takayuki Takimoto. Post-capillary pulmonary hypertension in patients with interstitial lung disease: An important but overlooked phenomenon. RESPIRATORY INVESTIGATION. 2022 1;60(1):180-181..(滝本宜之)
• 31. Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi, Kenji Sugio, Masahiro Tsuboi, Isamu Okamoto, Yasuo Iwamoto, Noriaki Sakakura, Shunichi Sugawara, Shinji Atagi, Toshiaki Takahashi, Hidetoshi Hayashi, Morihito Okada, Hidetoshi Inokawa, Hiroshige Yoshioka, Kazuhisa Takahashi, Masahiko Higashiyama, Ichiro Yoshino, Kazuhiko Nakagawa, West Japan Oncology Group. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT). JOURNAL OF CLINICAL ONCOLOGY. 2022 1;40(3):231-241.(安宅信二)
• 32. Majem M, Goldman JW, John T, Grohe C, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Li S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Atagi S, Zeng L, Kulkarni D, Medic N, Tsuboi M, Herbst RS, Wu YL. Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial. CLINICAL CANCER RESEARCH. 2022 1;(安宅信二)
• 33. Kawachi H, Tamiya M, Matsumoto K, Tamiya A, Yanase T, Tanizaki S, Kumagai T. Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study. INVESTIGATIONAL NEW DRUGS. 2022 1;40(3):634-642.(田宮朗裕)
• 34. Yu Kurahara, Takehiko Kobayashi, Kazunobu Tachibana, Kazunari Tsuyuguchi. The feasibility of rifampicin Re-administration in patients with tuberculosis and Clostridioides difficile infection. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy. 2022 1;28(4):558-562.(倉原優)
• 35. Baldi BG, Radzikowska E, Cottin V, Dilling DF, Ataya A, Carvalho CRR, Harari S, Koslow M, Grutters JC, Inoue Y, Gupta N, Johnson SR. COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition. Chest. S0012-3692(21)05166-7.(井上義一)
• 36. Suzuki K, Ikari T, Matsunuma R, Matsuda Y, Matsumoto Y, Miwa S, Mori M, Yamaguchi T, Watanabe H, Tanaka K. The Possibility of Conducting a Clinical Trial on Palliative Care: A Survey of Whether a Clinical Study on Cancer Dyspnea Is Acceptable to Cancer Patients and Their Relatives. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2021 12;62(6):1262-1272.(松田能宣)
• 37. Hiroyasu Kaneda, Kenji Sawa, Haruko Daga, Asuka Okada, Yuki Nakatani, Shinji Atagi, Kyoichi Okishio, Yoko Tani, Yoshiya Matsumoto, Koichi Ogawa, Kenji Nakahama, Motohiro Izumi, Shigeki Mitsuoka, Tomoya Kawaguchi. Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non-small cell lung cancer patients with asymptomatic brain metastases. INVESTIGATIONAL NEW DRUGS. 2021 12;39(6):1598-1603.(沖塩協一)
• 38. Miyako Satouchi, Kaname Nosaki, Toshiaki Takahashi, Kazuhiko Nakagawa, Keisuke Aoe, Takayasu Kurata, Akimasa Sekine, Atsushi Horiike, Tatsuro Fukuhara, Shunichi Sugawara, Shigeki Umemura, Hideo Saka, Isamu Okamoto, Nobuyuki Yamamoto, Hiroshi Sakai, Kazuma Kishi, Nobuyuki Katakami, Hidehito Horinouchi, Toyoaki Hida, Hiroaki Okamoto, Shinji Atagi, Tatsuo Ohira, Shi Rong Han, Kazuo Noguchi, Victoria Ebiana, Katsuyuki Hotta. First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset. CANCER SCIENCE. 2021 12;112(12):5000-5010.(安宅信二)
• 39. Ishiki H, Hasuo H, Matsuda Y, Matsuoka H, Hiramoto S, Higuchi M, Yoshida K, Tokoro A, Hatano Y, Hori T, Kinkawa J, Nojima M. Prevalence of myofascial pain syndrome and efficacy of trigger point injection in patients with incurable cancer. A multicenter, prospective observational study. (MyCar study). PAIN MEDICINE. 2021 12;10(1093):350.(松田能宣)
• 40. T. Arai; T. Kagawa; Y. Sasaki; R. Sugawara; C. Sugimoto; K. Tachibana; Y. Fujita; S. Hayashi; Y. Inoue. Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage: Predictive Role for Acute Exacerbation of Idiopathic Interstitial Pneumonias. CANADIAN RESPIRATORY JOURNAL. 2021 12;2021(1):4595019.(新井徹)
• 41. Murakami H, Horinouchi H, Harada H, Sobue T, Kato T, Atagi S, Kozuki T, Tokito T, Oizumi S, Seike M, Ohashi K, Mio T, Sone T, Jinushi M, Tsuboi M. Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: Expanded cohort of the SOLUTION study. LUNG CANCER. 2021 12;165152-163.(安宅信二)
• 42. Koji Azuma, Takayuki Takimoto, Takahiko Kasai, Masaki Hirose, Kazuyoshi Hatsuda, Chikatoshi Sugimoto, Toru Arai, Masanori Akira, Yoshikazu Inoue. Diagnostic yield and safety of bronchofiberscopy for pulmonary alveolar proteinosis. RESPIRATORY INVESTIGATION. 2021 11;59(6)757-765.(滝本宜之)
• 43. Mori M, Kawaguchi T, Imai K, Yokomichi N, Yamaguchi T, Suzuki K, Matsunuma R, Watanabe H, Maeda I, Matsumoto Y, Matsuda Y, Morita T; EASED Investigators.  Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2021 11;62(5):936-948.(松田能宣)
• 44. Yoshihiko Taniguchi. Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON). LUNG CANCER. 2021 11;16186-93.(谷口善彦)
• 45. Yu Kurahara, Takehiko Kobayashi, Sayoko Shintani, Yoshinobu Matsuda, Akihiro Tamiya, Reiko Sugawara, Toru Arai, Kazunobu Tachibana, Kyoichi Okishio, Hideo Matsui, Kazunari Tsuyuguchi. Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first-third waves with the fourth wave. RESPIRATORY INVESTIGATION. 2021 11;59(6):810-818.(倉原優)
• 46. Teiko Sakurai, Toru Arai, Masaki Hirose, Kensuke Kojima, Tetsuki Sakamoto, Yoshinobu Matsuda, Chikatoshi Sugimoto, Hyung-Eun Yoon, Yoshikazu Inoue. Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung. in lymphangioleiomyomatosisORPHANET JOURNAL OF RARE DISEASES. 2021 11;16(1):466.(広瀬雅樹)
• 47. Birring SS, Bushnell DM, Baldwin M, Mueller H, Male N, Rohr KB, Inoue Y. The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases. EUROPEAN RESPIRATORY JOURNAL. 2021 11;2101790.(井上義一)
• 48. Ryota Shintani, Akimasa Sekine, Kota Murohashi, Ryota Otoshi, Takeo Kasuya, Tsuneyuki Oda, Tomohisa Baba, Shigeru Komatsu, Takashi Ogura, Yoshikazu Inoue. Successful Treatment of Chylothorax and Chylopericardium by Radiotherapy in Lung Cancer. Internal medicine (Tokyo, Japan). 2021 11;8293-21.(新谷亮太)
• 49. Asako, Mizuki; Matsunaga, Hitomi; Nakahara, Wataru; Ikeda, Mako; Mima, Fuka; Minami, Ryota; Sekiguchi, Masahiro; Oka, Kazumasa; Wada, Naoki; Suzuki, Katsuhiro; Yoshizawa, Kazutaka; Sakagami, Takuro; Ueda, Shuji. Mycobacterial lymphadenitis without granuloma formation in a patient with anti-interferon-gamma antibodies. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2021 NOV;114(5):630-635.( 鈴木克洋)
• 50. Maeda I, Satomi E, Kiuchi D, Nishijima K, Matsuda Y, Tokoro A, Tagami K, Matsumoto Y, Naito A, Morita T, Iwase S; Phase-R N/V Study Group, Otani H, Odagiri T, Watanabe H, Mori M, Matsuda Y, Nagaoka H, Mayuzumi M, Kanai Y, Sakamoto N, Ariyoshi K. Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational study. SUPPORTIVE CARE IN CANCER. 2021 10;29(10):5831-5838.(所昭宏)
• 51. Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M; joint committee of Japanese Respiratory Society and Japan College of Rheumatology. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. RESPIRATORY INVESTIGATION. 2021 10;59(6):709-740.(井上義一)
• 52. Inoue Y, Suda T, Kitamura H, Okamoto M, Azuma A, Inase N, Kuwana M, Makino S, Nishioka Y, Ogura T, Takizawa A, Ugai H, Stowasser S, Schlenker-Herceg R, Takeuchi T. Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. RESPIRATORY MEDICINE. 2021 10;187106574.(井上義一)
• 53. K. Kojima; T. Sakamoto; T. Kasai; T. Kagawa; H. Yoon; S. Atagi. PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC. SCIENTIFIC REPORTS. 2021 9;11(1):17522.(小島健介)
• 54. Tokoro A, Imai H, Fumita S, Harada T, Noriyuki T, Gamoh M, Okamoto M, Akashi Y, Kizawa Y. Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J Study): A Post Hoc Analysis. JOURNAL OF CLINICAL MEDICINE. 2021 9;10(18):４１９３.(所昭宏)
• 55. Hasuo H, Ishiki H, Matsuda Y, Matsuoka H, Hiramoto S, Kinkawa J, Nojima M. The Usefulness of the Armchair Sign for the Diagnosis of Psychosomatic-Prone Myofascial Pain Syndrome in Patients with Incurable Cancer: A Secondary Analysis of a Prospective Multicenter Observational Clinical Study. PALLIATIVE MEDICINE REPORTS. 2021 9;2(1):250-254.(松田能宣)
• 56. Hiroshi Sakai, Masahiro Morise, Terufumi Kato, Shingo Matsumoto, Tomohiro Sakamoto, Toru Kumagai, Takaaki Tokito, Shinji Atagi, Toshiyuki Kozuki, Hiroshi Tanaka, Kenichi Chikamori, Naofumi Shinagawa, Hiroaki Takeoka, Rolf Bruns, Josef Straub, Karl Maria Schumacher, Paul K Paik. Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2021 8;51(8):1261-1268.(安宅信二)
• 57. Mizukoshi F, Kobayashi N, Kirikae F, Ohta K, Tsuyuguchi K, Yamada N, Inoue Y, Horiba M, Kawata N, Ichinose A, Miyoshi-Akiyama T, Kiritani R, Funatogawa K, Kirikae T. Molecular Epidemiology of Drug-Resistant Mycobacterium Tuberculosis in Japan. MSPHERE. 2021 8;6(4):e00978-20.(露口一成)
• 58. Hasuo H, Matsuoka H, Matsuda Y, Fukunaga M. The Immediate Effect of Trigger Point Injection With Local Anesthetic Affects the Subsequent Course of Pain in Myofascial Pain Syndrome in Patients With Incurable Cancer by Setting Expectations as a Mediator. FRONTIERS IN PSYCHIATRY. 2021 8;12:592776.(松田能宣)
• 59. Yukihiro Nakamura, Takayuki Takimoto, Takehiko Kobayashi, Kazunobu Tachibana, Takahiko Kasai, Masanobu Akira, Toru Arai, Yoshikazu Inoue. Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series. RESPIRATORY MEDICINE CASE REPORTS. 2021 8;34101498.(滝本宜之)
• 60. Tamiya M, Tamiya A, Suzuki H, Taniguchi Y, Katayama K, Minomo S, Nakao K, Takeuchi N, Matsuda Y, Naito Y, Shiroyama T, Okamoto N, Okishio K, Kumagai T, Atagi S, Imamura F, Hirashima T. Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion. INVESTIGATIONAL NEW DRUGS. 2021 8;39(4):1106-1112.(田宮朗裕)
• 61. Yu Kurahara. The Detachment Process of Aspergilloma Formation. INTERNAL MEDICINE. 2021 7;60(13):2153-2154.(倉原優)
• 62. Yu Kurahara. Massive Bronchorrhea. INTERNAL MEDICINE. 2021 7;60(13):2155-2156.(倉原優)
• 63. T.Arai; H. Matsuoka; M. Hirose; H. Kida; S.Yamamoto; Y. Ogata; M. Mori; K. Hatsuda; C. Sugimoto; K. Tachibana; M. Akira; Y. Inoue. Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin. BMJ OPEN RESPIRATORY RESEARCH. 2021 7;8(1):e000889.(新井徹)
• 64. Udagawa H, Sugiyama E, Harada T, Atagi S, Koyama R, Watanabe S, Nakamura Y, Harada D, Hataji O, Tanaka F, Kida H, Satouchi M, Maeno K, Inoue A, Yoh K, Yamane Y, Urata Y, Yoshioka H, Yamanaka T, Goto K. Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR). TRANSLATIONAL LUNG CANCER RESEARCH. 2021 7;10(7):3059-3070.(安宅信二)
• 65. Takatoshi Enomoto, Takayuki Takimoto, Tomoko Kagawa, Kazunobu Tachibana, Chikatoshi Sugimoto, Toru Arai, Teiko Sakurai, Takahiko Kasai, Masanori Akira, Seiji Hayashi, Yoshikazu Inoue. Histologically Proven Dendriform Pulmonary Ossification: A Five-case Series. INTERNAL MEDICINE. 2021 7;60(14):2261.(滝本宜之)
• 66. Sugimoto T, Fujimoto D, Sato Y, Tamiya M, Yokoi T, Tamiya A, Iwasawa S, Hata A, Uchida J, Fukuda Y, Hara S, Kanazu M, Hirano K, Kokubo M, Yamamoto N. Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study. INVESTIGATIONAL NEW DRUGS. 2021 6;39(3):853-859.(田宮朗裕)
• 67. Tamiya A, Isa SI, Taniguchi Y, Nakagawa H, Atagi S, Ando M, Koh Y. Prospective Observational Study of Treatment Resistance-related Gene Screening Using Plasma Circulating Tumor DNA in Third-generation EGFR-TKI Osimertinib Therapy (Elucidator). CLINICAL LUNG CANCER. 2021 5;22(3):e336-e341.(田宮朗裕)
• 68. Tamiya M, Tamiya A, Okamoto N, Taniguchi Y, Nishino K, Atagi S, Hirashima T, Imamura F, Kumagai T, Suzuki H. The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC. SCIENTIFIC REPORTS. 2021 5;11(1):9629.(田宮朗裕)
• 69. Matsuda Y, Morita T, Oyamada S, Ariyoshi K, Yamaguchi T, Iwase S. Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15). BMJ OPEN. 2021 5;11(5):(松田能宣)
• 70. Enomoto T, Inoue Y, Adachi Y, Kouno S, Inagaki Y, Azuma K, Katayama K, Takeuchi N, Matsuda Y.  Limitations of End-Tidal CO2 Measured with a Portable Capnometer to Estimate PaCO2 for Patients with Respiratory Disease. TURKISH THORACIC JOURNAL. 2021 5;22(3):212-216.(井上義一)
• 71. Matsumoto K, Nakamura Y, Inagaki Y, Taniguchi Y, Tamiya A, Matsuda Y, Kasai T, Atagi S. Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report. THORACIC CANCER. 2021 4;12(7):1137-1140.(安宅信二)
• 72. Hosoya K, Fujimoto D, Morimoto T, Kumagai T, Tamiya A, Taniguchi Y, Yokoyama T, Ishida T, Matsumoto H, Hirano K, Kominami R, Tomii K, Suzuki H, Hirashima T, Tanaka S, Uchida J, Morita M, Kanazu M, Mori M, Nagata K, Fukuda I, Tamiya M. Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study. BMC CANCER. 2021 4;21(1):346.(田宮朗裕)
• 73. Matsumoto K, Tamiya A, Matsuda Y, Taniguchi Y, Atagi S, Kawachi H, Tamiya M, Tanizaki S, Uchida J, Ueno K, Yanase T, Suzuki H, Hirashima T. Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study. TRANSLATIONAL LUNG CANCER RESEARCH. 2021 4;10(4):1642-1652.(田宮朗裕)
• 74. Takehiko Kobayashia, Kazunari Tsuyuguchib, Shiomi Yoshidab, Yohei Kimuraa,c, Taisuke Tsujia,d, Shojiro Minomoa, Yu Kuraharaa, Yoshikazu Inouee, Katsuhiro Suzukia. Resumption/Efficacy and safety of azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects by clarithromycin-containing regimen. RESPIRATORY INVESTIGATION. 2021 3;59(2):212-217.(小林岳彦)
• 75. Hiraku Tsujimoto, Yuki Kataoka, Yukihito Sato, Masahiro Banno, Emi Tsujino-Tsujimoto, Yukiyoshi Sumi, Ryuichi Sada, Takashi Fujiwara, Yoichi Ohtake, Junji Kumasawa, Haruki Imura, Yoshinobu Matsuda, Ryuhei So, Tomoko Kagawa, Takashi Yoshioka, Yu Uneno, Hiroyuki Nagano, Mai Akazawa, Takunori Hozumi, Yasushi Tsujimoto. A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivity. BMC MEDICAL EDUCATION. 2021 2;21(1):1-8.(香川智子)

和文原著・著書等

• 1. 露口一成. プライマリケア医のためのこれからの咳の診かた 結核・非結核性抗酸菌症. 治療. 2022;104(4):462-466.
• 2. 角甲純, 中村陽一, 西智弘, 高木雄亮, 松田能宣, 渡邊紘章, 笠原庸子, 合屋将, 小原弘之, 森雅紀, 山口崇. 呼吸困難を有する慢性進行性疾患患者に対する送風療法の有効性：システマティックレビュー・メタ解析. Palliative Care Research. 2022;17(1):33-42.
• 3. 倉原優. 新型コロナワクチンによるアナフィラキシーの症例定義. 日本医事新報. 2022;(5057):56.
• 4. 倉原優. 新型コロナとロシア軍. 日本医事新報. 2022;(5108):58.
• 5. 倉原優. 日本が直面する高齢者の風邪診療に. 総合診療. 2022;32(3):157.
• 6. 倉原優. 吸入ステロイドと緑膿菌の関係. J-IDEO. 2022;6(2):360-361.
• 7. 倉原優. 大阪府の新型コロナ死者が多い理由. 日本医事新報. 2022;(5106):54.
• 8. 倉原優. クロファジミンの歴史. 結核. 2022;97(2):105-110.
• 9. 日本結核・非結核性抗酸菌症学会治療委員会. イソニコチン酸ヒドラジドが使用できない場合の結核治療について. 結核. 2022;97(2):125-127.
• 10. 大槻登季子. 結核院内感染対策
  結核病棟を有する医療施設における感染管理認定看護師の役割. 保健師・看護師の結核展望. 2022;118(59):51～58.
• 11. 井上義一, 新井徹, 清水重喜, 澄川裕充. 慢性線維化性間質性肺炎における血液バイオマーカー：MDD診断での位置づけ. 呼吸器内科. 2022;41(2):172-179.
• 12. 倉原優. 気管支喘息、COPD急性増悪.  改訂版ER実践ハンドブック. 2022;
• 13. 露口一成. 結核と非結核性抗酸菌症Up to Date-診断、治療、感染対策、発病予防 多剤耐性結核の治療. 医学のあゆみ. 2022;280(6):641-646.
• 14. 稲垣雄士. 炎症性腸疾患を基礎疾患にもつがん患者への免疫チェックポイント阻害薬の治療. 医学論文の読み方2.0 論文を批判的に吟味し臨床適用するためのLetterの書き方. 2022;P154-160.
• 15. 倉原優. 感染者の隔離期間の短縮が再び議論へ. 日本医事新報. 2022;(5100):56-57.
• 16. 倉原優. 水道水を抗酸菌染色したらどうなる？. J-IDEO. 2022;6(1):156-157.
• 17. 倉原優. コロナ第5波の収束要因と今後の医療提供体制の展望. コミュニティケア. 2022;24(2):32-35.
• 18. 倉原優. イスコチン. なんで使うの？そのくすり.. 2022;P40-43.
• 19. 倉原優. リファンピシン. なんで使うの？そのくすり.. 2022;P44-46.
• 20. 倉原優. レジデントのための専門科コンサルテーション. 臨床外科. 2022;77(1):50.
• 21. 菅野康二, 長谷川貴昭, 稲田修士, 原島沙季, 松田能宣, 谷向仁. がん治療におけるせん妄への対応. 癌と化学療法. 2022;49(1):7.
• 22. 井上 康.  33.「慢性呼吸不全」. 呼吸器内科学レビュー2022-‘23. 2021; P.240-246.
• 23. 倉原優. 医師の賃金を議論する前に. 日本医事新報. 2021;(5095):58.
• 24. 倉原優. 新型コロナ病棟ナース戦記. 新型コロナ病棟ナース戦記. 2021;
• 25. 倉原優. 喀血・血痰. 総合診療. 2021;31(12):1484-1487.
• 26. 露口一成. 粟粒結核. 別冊日本臨床 呼吸器症候群（第3版）Ⅳ. 2021;2084～87.
• 27. 松田能宣 . 終末期医療. みんなの呼吸器Respica. 2021;(冬季増刊号):123-128.
• 28. 倉原優. いつも悩ましい、片側大量胸水. J-IDEO. 2021;5(6):944-945.
• 29. 倉原優. 胸水. 呼吸器ジャーナル. 2021;69(4):564-79.
• 30. 玉舍 学. 剥離性間質性肺炎(DIP). 呼吸器症候群（第3版）Ⅲ. 2021;77-80.
• 31. 倉原優. 世の中にトンデモ医療本があふれる理由. 日本医事新報. 2021;(5090):60.
• 32. 小林岳彦. 特集 呼吸器救急と呼吸管理. 呼吸器ジャーナル. 2021;69(4):496-503.
• 33. 澄川裕充, 清水重喜. 病態や形態学的な特徴を示す言葉と疾患名としての用語の使い分けは？. 画像診断. 2021;41(13):1401-1409.
• 34. 倉原優. ワクチン・検査パッケージ戦略が現実に. 日本医事新報. 2021;(5087):56.
• 35. 倉原優. 医師や学会のSNSアカウントのメリット・デメリット. 日本医事新報. 2021;(5084):63-64.
• 36. 沖塩協一. 特集 肺がん. 健康ライフさかい. 2021;(23):P1-P5.
• 37. 浅見貴弘, 森本耕三, 小林岳彦, 南宮湖, 長谷川直樹. 市民公開講座参加者のアンケートからみる
      肺非結核性抗酸菌症の現状と課題. 結核. 2021;96(6):153-160.
• 38. 倉原優. ついに実現、吸入アミカシン. J-IDEO. 2021;5(5):792-793.
• 39. 露口一成. ポストコロナに備えるべき日常感染症－動向・対策・治療の基本まで ⑤結核・多剤耐性結核. 感染と抗菌薬. 2021;24(3):179-183.
• 40. 日本結核・非結核性抗酸菌症学会治療委員会. 多剤耐性結核の治療におけるリネゾリドの利用について. 結核. 2021;96(6):183-185.
• 41. 松田能宣. 喘息の心理療法、心身医学的治療. アレルギーの臨床. 2021;41(10):868～871.
• 42. 内藤明美, 森田達也, 田村恵子, 大屋清文, 松田能宣, 田上恵太, 柏木秀行, 大谷弘行. スピリチュアルペインに関する緩和ケア医と精神科医の認識に関する全国調査. Palliative Care Research. 2021;16(2):115～122.
• 43. 井上真一郎, 谷向仁, 松田能宣, 奥山徹. 緩和ケアにおけるせん妄. 臨床精神医学. 2021;50(8):829～837.
• 44. 竹内奈緒子, 新井徹, 井上義一. 膠原病肺、肺胞蛋白症（PAP）. 見る診るわかる！ 胸部画像診断. 2021;130～138、175～181.
• 45. 倉原優. 新型コロナワクチンに関する医療従事者のデマゴーグ. 日本医事新報. 2021;(5075):62.
• 46. 倉原優. 肺非結核性抗酸菌症ガイドライン（ATS/ERS/ESCMID/IDSA）.  臨床と微生物. 2021;48(4):63-9.
• 47. 山田 多加. 多職種協働で取り組む医療安全活動の効果. 医療の広場. 2021;61(7):31-34.
• 48. 倉原優. コロナ禍のTwitter－ナッジ理論の後押しと抑うつ傾向. 日本医事新報. 2021;(5071):63-64.
• 49. 小林 雅. 呼吸器疾患に特化した当院における、心エコーでの計測値と高感度TnI値との相関性の検討. 医療の広場. 2021;61(6):31-34.
• 50. 小林雅, 上西珠実, 福田和弘, 水谷美香, 土田麗央奈, 濱奈緒子, 佐々木達彦, 樋口冨士夫, 玉舍学, 笠井孝彦. 呼吸器疾患に特化した当院における、心エコーでの計測値と高感度TnI値との相関性の検討. 医療の広場. 2021;61(6):31-34.
• 51. 倉原優. マスコミに振り回される新型コロナワクチン施策. 日本医事新報. 2021;(5067):59-60.
• 52. 所昭宏. 新型コロナウイルス感染症受け入れ病院における心療内科医活動記. 日本心療内科学会誌. 2021;25(2):117-119.
• 53. 倉原優. 喘息増悪時の最適治療は？. 救急外来、ここだけの話. 2021;P105-110.
• 54. 倉原優. 薬剤性肺障害でしょうか？感染症でしょうか？. J-IDEO. 2021;5(4): 596-597.
• 55. 倉原優. 大阪府におけるコロナ第4波の病床逼迫. 日本医事新報. 2021;(5061):58.
• 56. 倉原優. ポケット呼吸器診療2021. ポケット呼吸器診療2021. 2021;
• 57. 倉原優. 気管支喘息—アクションプランで救急外来受診を減らそう！. medicina. 2021;58(4):106-9.
• 58. 沖塩協一. 免疫チェックポイント阻害薬による癌治療の. 堺市医師会報. 2021;(70):P6-P.11.
• 59. 倉原優. 喘息・COPDの治療薬. レジデントノート. 2021;22(18):3106-3114.
• 60. 倉原優. 慢性咳嗽. medicina. 2021;58(2):1983-97.

2025年1月8日掲載

2020年度英文論文

• 1. K. Matsumoto, Y. Nakamura, Y. Inagaki, Y. Taniguchi, A. Tamiya, Y. Matsuda, T. Kasai, S. Atagi. Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report. Thoracic Cancer. 2021 Apr;12(7):1137ー1140.(松本錦之介)
• 2. N. Tanabe, H. Kumamaru, Y. Tamura, H. Taniguchi, N. Emoto, Y. Yamada, O. Nishiyama, I. Tsujino, H. Kuraishi, Y. Nishimura, H. Kimura, Y. Inoue, Y. Morio, Y. Nakatsumi, T. Satoh, M. Hanaoka, K. Kusaka, M. Sumitani, T. Handa, S. Sakao, T. Kimura, Y. Kondoh, K. Nakayama, K. Tanaka, H. Ohira, M. Nishimura, H. Miyata, K. Tatsumi. Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases. Circulation Journal. 2021 Apr;85(4):333ー342.(井上義一)
• 3. T. Koba, Y. Takeda, R. Narumi, T. Shiromizu, Y. Nojima, M. Ito, M. Kuroyama, Y. Futami, T. Takimoto, T. Matsuki, R. Edahiro, S. Nojima, Y. Hayama, K. Fukushima, H. Hirata, S. Koyama, K. Iwahori, I. Nagatomo, M. Suzuki, Y. Shirai, T. Murakami, K. Nakanishi, T. Nakatani, Y. Suga, K. Miyake, T. Shiroyama, H. Kida, T. Sasaki, K. Ueda, K. Mizuguchi, J. Adachi, T. Tomonaga, A. Kumanogoh. Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres. ERJ Open Res. 7(1):(滝本宜之)
• 4. I. Maeda, E. Satomi, D. Kiuchi, K. Nishijima, Y. Matsuda, A. Tokoro, K. Tagami, Y. Matsumoto, A. Naito, T. Morita, S. Iwase, H. Otani, T. Odagiri, H. Watanabe, M. Mori, Y. Matsuda, H. Nagaoka, M. Mayuzumi, Y. Kanai, N. Sakamoto, K. Ariyoshi. Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational study. Supportive Care in Cancer. 2021 Mar;8.(松田能宣)
• 5. H. Itami, T. Fujii, T. Nakai, M. Takeda, Y. Kishi, F. Taniguchi, C. Terada, F. Okada, Y. Nitta, M. Matsuoka, S. Sasaki, S. Sugimoto, T. Uchiyama, K. Morita, T. Kasai, R. Kawaguchi, C. Ohbayashi. TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma. Hum Pathol. 11159ー66.(武田麻衣子)
• 6. M. Hirose, T. Arai, C. Sugimoto, T. Takimoto, R. Sugawara, S. Minomo, S. Shintani, N. Takeuchi, K. Katayama, Y. Inoue, T. Kagawa, T. Kasai, M. Akira, Y. Inoue. B cell-activating factors in autoimmune pulmonary alveolar proteinosis. Orphanet Journal of Rare Diseases. 2021 Mar;16(1):10.(広瀬雅樹)
• 7. T. Enomoto, A. Tamiya, K. Matsumoto, Y. Adachi, K. Azuma, Y. Inagaki, S. Kouno, Y. Taniguchi, N. Saijo, K. Okishio, S. Atagi. Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer. Clinical & Translational Oncology. 2021 Mar;23(3):582ー590.(田宮朗裕)
• 8. S. Minomo, T. Kobayashi, K. Katayama, M. Ryuge, T. Kagawa, K. Tsuyuguchi, H. Matsui, K. Suzuki. Risk factors for hemoptysis in Mycobacterium avium complex lung disease. Respiratory Investigation. 2021 Mar;59(2):218ー222.(蓑毛祥次郎)
• 9. T. Johkoh, K. S. Lee, M. Nishino, W. D. Travis, J. H. Ryu, H. Y. Lee, C. J. Ryerson, T. Franquet, A. A. Bankier, K. K. Brown, J. M. Goo, H. U. Kauczor, D. A. Lynch, A. G. Nicholson, L. Richeldi, C. M. Schaefer-Prokop, J. Verschakelen, S. Raoof, G. D. Rubin, C. Powell, Y. Inoue, H. Hatabu. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society. Chest. 2021 Mar;159(3):1107ー1125.(井上義一)
• 10. H. Kitaoka, H. Kobayashi, T. Takimoto, T. Kijima. Proposal of selective wedge instillation of pulmonary surfactant for COVID-19 pneumonia based on computational fluid dynamics simulation. Bmc Pulmonary Medicine. 2021 Feb;21(1):5.(滝本宜之)
• 11. S. Sakaue, E. Yamaguchi, Y. Inoue, M. Takahashi, J. Hirata, K. Suzuki, S. Ito, T. Arai, M. Hirose, Y. Tanino, T. Nikaido, T. Ichiwata, S. Ohkouchi, T. Hirano, T. Takada, S. Miyawaki, S. Dofuku, Y. Maeda, T. Nii, T. Kishikawa, K. Ogawa, T. Masuda, K. Yamamoto, K. Sonehara, R. Tazawa, K. Morimoto, M. Takaki, S. Konno, M. Suzuki, K. Tomii, A. Nakagawa, T. Handa, K. Tanizawa, H. Ishii, M. Ishida, T. Kato, N. Takeda, K. Yokomura, T. Matsui, M. Watanabe, H. Inoue, K. Imaizumi, Y. Goto, H. Kida, T. Fujisawa, T. Suda, T. Yamada, Y. Satake, H. Ibata, N. Hizawa, H. Mochizuki, A. Kumanogoh, F. Matsuda, K. Nakata, T. Hirota, M. Tamari, Y. Okada. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nature Communications. 2021 Feb;12(1):6.(井上義一)
• 12. H. Tsujimoto, Y. Kataoka, Y. Sato, M. Banno, E. Tsujino-Tsujimoto, Y. Sumi, R. Sada, T. Fujiwara, Y. Ohtake, J. Kumasawa, H. Imura, Y. Matsuda, R. So, T. Kagawa, T. Yoshioka, Y. Uneno, H. Nagano, M. Akazawa, T. Hozumi, Y. Tsujimoto. A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivity. BMC Med Educ. 21(1):98.(松田能宣)
• 13. Y. Kurahara. Massive Bronchorrhea. Intern Med. (倉原優)
• 14. Y. Kurahara. The Detachment Process of Aspergilloma Formation. Intern Med. (倉原優)
• 15. T. Enomoto, T. Takimoto, T. Kagawa, K. Tachibana, C. Sugimoto, T. Arai, T. Sakurai, T. Kasai, M. Akira, S. Hayashi, Y. Inoue. Histologically Proven Dendriform Pulmonary Ossification: A Five-case Series. Intern Med. (榎本貴俊)
• 16. A. Takizawa, M. Kamita, Y. Kondoh, M. Bando, M. Kuwana, Y. Inoue. Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union. Current Medical Research and Opinion. 2021 Feb;37(2):327ー339.(井上義一)
• 17. N. Ose, Y. Takeuchi, N. Kitahara, A. Matumura, K. Kodama, H. Shiono, Y. Susaki, Y. Funakoshi, H. Takabatake, Y. Shintani, U. Thoracic Surg Study Grp Osaka. Analysis of pulmonary nodules caused by nontuberculous mycobacteriosis in 101 resected cases: multi-center retrospective study. Journal of Thoracic Disease. 2021 Feb;13(2):977ー985.(松村晃秀)
• 18. T. Johkoh, K. S. Lee, M. Nishino, W. D. Travis, J. H. Ryu, H. Y. Lee, C. J. Ryerson, T. Franquet, A. A. Bankier, K. K. Brown, J. M. Goo, H. U. Kauczor, D. A. Lynch, A. G. Nicholson, L. Richeldi, C. M. Schaefer-Prokop, J. Verschakelen, S. Raoof, G. D. Rubin, C. Powell, Y. Inoue, H. Hatabu. Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society. Radiology. 298(3):550ー566.(井上義一)
• 19. T. Takimoto, H. Kitaoka, T. Kijima. What Is Tracheobronchomalacia in Obstructive Lung Disease?. Chest. 159(1):442ー443.(滝本宜之)
• 20. Yoshinobu Matsuda, Tatsuya Morita, Hirotaka Matsumoto, Keita Hosoi, Kayo Kusama, Yasuo Kohashi, Hiroshi Morishita, Sawako Kaku, Keisukie Ariyoshi, Shunsuke Oyamada, Yoshikazu Inoue, Satoru Iwase, Takuhiro Yamaguchi, and Mitsunori Nishikawa. Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07. Palliat Med Reports. 2021 Jan;2(1):(松田能宣)
• 21. T. Harada, H. Imai, S. Fumita, T. Noriyuki, M. Gamoh, M. Okamoto, Y. Akashi, Y. Kizawa, A. Tokoro. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer. International Journal of Clinical Oncology. 2021 Jan;26(1):104ー110.(所昭宏)
• 22. H. Saka, M. Nishio, T. Hida, K. Nakagawa, H. Sakai, N. Nogami, S. Atagi, T. Takahashi, H. Horinouchi, M. Takenoyama, N. Katakami, H. Tanaka, K. Takeda, M. Satouchi, H. Isobe, M. Maemondo, K. Goto, T. Hirashima, K. Minato, N. Yada, T. Tamura. Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies. Japanese Journal of Clinical Oncology. 2021 Jan;51(1):106ー113.(安宅信二)
• 23. Y. Adachi, T. Takimoto, M. Takeda, K. Matsumoto, N. Takeuchi, T. Kagawa, T. Sakamoto, T. Kasai, C. Sugimoto, Y. Inoue, K. Tachibana, T. Arai, Y. Inoue. Lymphoplasmacytic lymphoma involving the mediastinum and the lung, followed by amyloidosis: A surgically and genetically proven case. Respiratory Medicine Case Reports. 2020;315.(滝本宜之)
• 24. Taniguchi Y, Tamiya A, Matsuda Y, Adachi Y, Enomoto T, Azuma K, Kouno S, Tokoro A, Atagi S. Opioids impair Nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer. BMJ Supportive & Palliative Care. 2020 Dec;10(谷口善彦)
• 25. N. Nishiyama, Y. Matsuda, N. Fujiwara, K. Ariyoshi, S. Oyamada, K. Narita, R. Ishii, S. Iwase. The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02). Bmc Palliative Care. 2020 Oct;19(1):8.(松田能宣)
• 26. Y. Inagaki, A. Tamiya, Y. Matsuda, K. Azuma, Y. Adachi, T. Enomoto, S. Kouno, Y. Taniguchi, N. Saijo, K. Okishio, S. Atagi. Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma A case report. Medicine. 2020 Oct;99(42):4.(稲垣雄士)
• 27. K. Yoh, S. Atagi, M. Reck, E. B. Garon, S. Ponce Aix, D. Moro-Sibilot, K. B. Winfree, B. Frimodt-Moller, A. Zimmermann, C. Visseren-Grul, K. Nakagawa. Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer. Current Medical Research and Opinion. 2020 Oct;36(10):1667ー1675.(安宅信二)
• 28. B. C. Trapnell, Y. Inoue, F. Bonella, C. Morgan, S. Jouneau, E. Bendstrup, I. Campo, S. A. Papiris, E. Yamaguchi, E. Cetinkaya, M. M. Ilkovich, M. R. Kramer, M. Veltkamp, M. Kreuter, T. Baba, C. Ganslandt, I. Tarnow, G. Waterer, T. Jouhikainen. Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis. New England Journal of Medicine. 2020 Oct;383(17):1635ー1644.(井上義一)
• 29. Mori M, Yamaguchi T, Matsuda Y, Suzuki K, Watanabe H, Matsunuma R, Kako J, Imai K, Usui Y, Matsumoto Y, Hui D, Currow D, Morita T. Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer. ESMO Open. 2020 Sep;(松田能宣)
• 30. H. Ishiki, J. Hamano, H. Nagaoka, Y. Matsuda, A. Tokoro, H. Matsuoka, H. Izumi, A. Sakashita, Y. Kizawa, S. Oyamada, T. Yamaguchi, S. Iwase. Prevalence of Extrapyramidal Symptoms in Cancer Patients Referred to Palliative Care: A Multicenter Observational Study (JORTC PAL12). American Journal of Hospice & Palliative Medicine. 7.(松田能宣)
• 31. R. Wang, T. Yamada, K. Kita, H. Taniguchi, S. Arai, K. Fukuda, M. Terashima, A. Ishimura, A. Nishiyama, A. Tanimoto, S. Takeuchi, K. Ohtsubo, K. Yamashita, T. Yamano, A. Yoshimura, K. Takayama, K. Kaira, Y. Taniguchi, S. Atagi, H. Uehara, R. Hanayama, I. Matsumoto, X. Han, K. Matsumoto, W. Wang, T. Suzuki, S. Yano. Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer, Nature Communications. 2020 Sep;11(1):14.(安宅信二)
• 32. Y. Suzuki, T. Fujisawa, H. Sumikawa, T. Tanaka, C. Sugimoto, M. Kono, H. Hozumi, M. Karayama, K. Furuhashi, N. Enomoto, Y. Nakamura, N. Inui, T. Suda. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis. Respiratory Medicine. 2020 Sep;1717.(杉本親寿)
• 33. K. Ogawa, Y. Koh, H. Kaneda, M. Izumi, Y. Matsumoto, K. Sawa, M. Fukui, Y. Taniguchi, N. Yoshimoto, A. Tamiya, M. Ando, A. Kubo, S. I. Isa, H. Saka, A. Matsumura, T. Kawaguchi. Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan. Bmj Open. 2020;10(9):8.(田宮朗裕)
• 34. H. Horinouchi, S. Atagi, S. Oizumi, K. Ohashi, T. Kato, T. Kozuki, M. Seike, T. Sone, T. Sobue, T. Tokito, H. Harada, T. Maeda, T. Mio, I. Shirosaka, K. Hattori, E. Shin, H. Murakami. Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study. Cancer Medicine. 2020 Sep;9(18):6597-6608.(安宅信二)
• 35. K. Katayama, M. Hirose, T. Arai, K. Hatsuda, K. Tachibana, R. Sugawara, C. Sugimoto, T. Kasai, M. Akira, Y. Inoue. Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis. Orphanet Journal of Rare Diseases. 2020 Sep;15(1):10.(片山加奈子)
• 36. T. Takimoto, T. Kagawa, K. Tachibana, T. Arai, Y. Inoue. Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti-interleukin-5 receptor antibody. Respirology Case Reports. 2020 Aug;8(6):3.(滝本宜之)
• 37. A. Tamiya, M. Tamiya, H. Go, T. Inoue, K. Kunimasa, K. Nakahama, Y. Taniguchi, T. Shiroyama, S. I. Isa, K. Nishino, T. Kumagai, H. Suzuki, T. Hirashima, S. Atagi, A. Shintani, F. Imamura. A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer. Anticancer Research. 2020 Aug;40(8):4229ー4236.(田宮朗裕)
• 38. G. Raghu, M. Remy-Jardin, C. J. Ryerson, J. L. Myers, M. Kreuter, M. Vasakova, E. Bargagli, J. H. Chung, B. F. Collins, E. Bendstrup, H. A. Chami, A. T. Chua, T. J. Corte, J. C. Dalphin, S. K. Danoff, J. Diaz-Mendoza, A. Duggal, R. Egashira, T. Ewing, M. Gulati, Y. Inoue, A. R. Jenkins, K. A. Johannson, T. Johkoh, M. Tamae-Kakazu, M. Kitaichi, S. L. Knight, D. Koschel, D. J. Lederer, Y. Mageto, L. A. Maier, C. Matiz, F. Morell, A. G. Nicholson, S. Patolia, C. A. Pereira, E. A. Renzoni, M. L. Salisbury, M. Selman, S. L. F. Walsh, W. A. Wuyts, K. C. Wilson, S. Amer Thoracic, S. Japanese Resp, T. Assoc Latinoamer. Diagnosis of Hypersensitivity Pneumonitis in Adults An Official ATS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2020 Aug;202(3):E36ーE69.(井上義一)
• 39. T. Arai, M. Akira, C. Sugimoto, K. Tachibana, Y. Inoue, S. Shintani, T. Okuma, T. Kasai, S. Hayashi, Y. Inoue. Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study. Journal of Thoracic Disease. 2020 Aug;12(8):4132ー+.(新井徹)
• 40. K. Okishio, R. Morita, J. Shimizu, H. Saito, H. Sakai, Y. H. Kim, O. Hataji, M. Yomota, M. Nishio, K. Aoe, O. Kanai, T. Kumagai, K. Kibata, H. Tsukamoto, S. Oizumi, D. Fujimoto, H. Tanaka, K. Mizuno, T. Masuda, T. Kozuki, T. Haku, H. Suzuki, I. Okamoto, H. Hoshiyama, N. Yada, Y. Ohe. Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR). Esmo Open. 2020 Jul;5(4):10.(沖塩協一)
• 41. T. Yanagihara, Y. Inoue. Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases. Curr Opin Pulm Med. 26(5):507ー517.(井上義一)
• 42. H. Hatabu, G. M. Hunninghake, L. Richeldi, K. K. Brown, A. U. Wells, M. Remy-Jardin, J. Verschakelen, A. G. Nicholson, M. B. Beasley, D. C. Christiani, R. San José Estépar, J. B. Seo, T. Johkoh, N. Sverzellati, C. J. Ryerson, R. Graham Barr, J. M. Goo, J. H. M. Austin, C. A. Powell, K. S. Lee, Y. Inoue, D. A. Lynch. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respiratory Medicine. 2020 Jul;8(7):726ー737.(井上義一)
• 43. A. Tamiya, S. I. Isa, Y. Taniguchi, H. Nakagawa, S. Atagi, M. Ando, Y. Koh. Prospective Observational Study of Treatment Resistance-related Gene Screening Using Plasma Circulating Tumor DNA in Third-generation EGFR-TKI Osimertinib Therapy (Elucidator). Clin Lung Cancer. (田宮朗裕)
• 44. T. Arai, T. Kasai, K. Shimizu, K. Kawahara, K. Katayama, C. Sugimoto, M. Hirose, H. Okamoto, K. Tachibana, M. Akira, Y. Inoue. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibodv. Internal Medicine. 2020;59(20):2539ー2546.(新井徹)
• 45. Yoshinobu Matsuda, Ryo Matsunuma, Kozue Suzuki, Masanori Mori, Hiroaki Watanabe, and Takashi Yamaguchi. Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians. Palliat Med Reports. 2020 Jul;1(1):(松田能宣)
• 46. Y. Adachi, K. Tsuyuguchi, T. Kobayashi, Y. Kurahara, S. Yoshida, T. Kagawa, S. Hayashi, K. Suzuki. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease. Journal of Infection and Chemotherapy. 2020 Jul;26(7):676ー680.(足立雄一)
• 47. S. Minomo, T. Arai, H. Higo, T. Tsuji, K. Tachibana, M. Akira, Y. Inoue. Characteristics and prognosis of interstitial pneumonias complicated with pneumomediastinum. Respiratory Investigation. 2020 Jul;58(4):262ー268.(蓑毛祥次郎)
• 48. G. D. Rubin, C. J. Ryerson, L. B. Haramati, N. Sverzellati, J. P. Kanne, S. Raoof, N. W. Schluger, A. Volpi, J. J. Yim, I. B. K. Martin, D. J. Anderson, C. Kong, T. Altes, A. Bush, S. R. Desai, J. Goldin, J. M. Goo, M. Humbert, Y. Inoue, H. U. Kauczor, F. Luo, P. J. Mazzone, M. Prokop, M. Remy-Jardin, L. Richeldi, C. M. Schaefer-Prokop, N. Tomiyama, A. U. Wells, A. N. Leung. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. Chest. 2020 Jul;158(1):106ー116.(井上義一)
• 49. R. Matsunuma, K. Suzuki, Y. Matsuda, M. Mori, H. Watanabe, T. Yamaguchi. Palliative care physicians' perspectives of management for terminally ill cancer patients with death rattle: a nationwide survey. Japanese Journal of Clinical Oncology. 2020 Jul;50(7):830ー833.(松田能宣)
• 50. H. Kobayashi, T. Takimoto, H. Kitaoka, T. Kijima. Aerosol spread with use of high-flow nasal cannulae: a computational fluid dynamics analysis. J Hosp Infect. 106(1):204ー205.(小林岳彦)
• 51. T. Takimoto, S. Minomo, K. Azuma, K. Tsuyuguchi, K. Suzuki. A rare cause of pneumatosis intestinalis: Intestinal amyloidosis reactive to pulmonary Mycobacterium avium infection. Int J Infect Dis. 97329ー330.(滝本宜之)
• 52. N. Eura, T. K. Matsui, J. Luginbühl, M. Matsubayashi, H. Nanaura, T. Shiota, K. Kinugawa, N. Iguchi, T. Kiriyama, C. Zheng, T. Kouno, Y. J. Lan, P. Kongpracha, P. Wiriyasermkul, Y. M. Sakaguchi, R. Nagata, T. Komeda, N. Morikawa, F. Kitayoshi, M. Jong, S. Kobashigawa, M. Nakanishi, M. Hasegawa, Y. Saito, T. Shiromizu, Y. Nishimura, T. Kasai, M. Takeda, H. Kobayashi, Y. Inagaki, Y. Tanaka, M. Makinodan, T. Kishimoto, H. Kuniyasu, S. Nagamori, A. R. Muotri, J. W. Shin, K. Sugie, E. Mori. Brainstem Organoids From Human Pluripotent Stem Cells. Frontiers in Neuroscience. 2020 Jun;1414.(武田麻衣子)
• 53. A. U. Wells, K. R. Flaherty, K. K. Brown, Y. Inoue, A. Devaraj, L. Richeldi, T. Moua, B. Crestani, W. A. Wuyts, S. Stowasser, M. Quaresma, R. G. Goeldner, R. Schlenker-Herceg, M. Kolb. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respiratory Medicine. 2020 May;8(5):453ー460.(井上義一)
• 54. I. Okamoto, H. Nokihara, S. Nomura, S. Niho, S. Sugawara, H. Horinouchi, K. Azuma, Y. Yoneshima, H. Murakami, Y. Hosomi, S. Atagi, T. Ozaki, A. Horiike, Y. Fujita, H. Okamoto, M. Ando, N. Yamamoto, Y. Ohe, K. Nakagawa. Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer A Phase 3 Randomized Clinical Trial. Jama Oncology. 2020 May;6(5):9.(安宅信二)
• 55. Y. Matsuda, H. Tanimukai, S. Inoue, S. Inada, K. Sugano, H. Hasuo, M. Yoshimura, S. Wada, C. Dotani, H. Adachi, Y. Okamoto, M. Takeuchi, D. Fujisawa, J. Kako, C. Sasaki, Y. Kishi, N. Akizuki, M. Inagaki, Y. Uchitomi, E. Matsushima, T. Okuyama. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Japanese Journal of Clinical Oncology. 2020 May;50(5):586ー593.(松田能宣)
• 56. Y. Inoue, R. J. Kaner, J. Guiot, T. M. Maher, S. Tomassetti, S. Moiseev, M. Kuwana, K. K. Brown. Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. Chest. 158(2):646ー659.(井上義一)
• 57. A. Tamiya, Y. Koh, S. I. Isa, A. Kubo, M. Ando, H. Saka, N. Yoshimoto, S. Takeo, H. Adachi, T. Tagawa, O. Kawashima, M. Yamashita, K. Kataoka, M. Takenoyama, Y. Takeuchi, K. Watanabe, A. Matsumura, T. Kawaguchi. Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study. Cancer Medicine. 2020 Apr;9(7):2343ー2351.(田宮朗裕)
• 58. Y. Inagaki, K. Tachibana, Y. Inoue, T. Kasai, Y. Inoue. Severe clopidogrel-induced DRESS with eosinophilic pneumonia associated with Epstein-Barr virus reactivation. Respirology Case Reports. 2020 Apr;8(3):4.(稲垣雄士)
• 59. Y. Minegishi, A. Gemma, S. Homma, K. Kishi, A. Azuma, T. Ogura, N. Hamada, H. Taniguchi, N. Hattori, Y. Nishioka, K. Tanizawa, T. Johkoh, T. Yokoyama, K. Mori, Y. Taguchi, M. Ebina, N. Inase, K. Hagiwara, H. Ohnishi, H. Mukae, Y. Inoue, K. Kuwano, H. Chiba, K. Ohta, Y. Tanino, F. Sakai, Y. Sugiyama. Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan. Erj Open Research. 2020 Apr;6(2):9.(井上義一)
• 60. T. Arai, H. Kida, Y. Ogata, S. Marumo, H. Matsuoka, I. Gohma, S. Yamamoto, M. Mori, C. Sugimoto, K. Tachibana, M. Akira, Y. Inoue. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: Secondary analysis of the SETUP trial. BMJ Open Respiratory Research. 2020 Mar;7(1):11.(新井徹)
• 61. R. Morita, K. Okishio, J. Shimizu, H. Saito, H. Sakai, Y. H. Kim, O. Hataji, M. Yomota, M. Nishio, K. Aoe, O. Kanai, T. Kumagai, K. Kibata, H. Tsukamoto, S. Oizumi, D. Fujimoto, H. Tanaka, K. Mizuno, T. Masuda, T. Kozuki, T. Haku, H. Suzuki, I. Okamoto, H. Hoshiyama, J. Ueda, Y. Ohe. Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan. Lung Cancer. 2020 Feb;1408ー18.(沖塩協一)
• 62. Y. Kondoh, A. Azuma, Y. Inoue, T. Ogura, S. Sakamoto, K. Tsushima, T. Johkoh, K. Fujimoto, K. Ichikado, Y. Matsuzawa, T. Saito, K. Kishi, K. Tomii, N. Sakamoto, M. Aoshima, J. Araya, S. Izumi, M. Arita, M. Abe, H. Yamauchi, J. Shindoh, T. Suda, M. Okamoto, M. Ebina, Y. Yamada, Y. Tohda, T. Kawamura, Y. Taguchi, H. Ishii, N. Hashimoto, S. Abe, H. Taniguchi, J. Tagawa, K. Bessho, N. Yamamori, S. Homma. Thrombomodulin alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Randomized, Double-blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 201(9):1110ー1119.(井上義一)
• 63. T. Kobayashi, K. Tsuyuguchi, S. Yoshida, Y. Kurahara, S. Minomo, Y. Inoue, K. Suzuki. Serum immunoglobulin a antibodies to glycopeptidolipid core antigen for Mycobacteroides abscessus complex lung disease. International Journal of Mycobacteriology. 2020 Jan-Mar;9(1):76ー82.(小林岳彦)
• 64. K. Nakata, T. Sugi, K. Kuroda, K. Yoshizawa, T. Takada, R. Tazawa, T. Ueda, A. Aoki, M. Abe, K. Tatsumi, R. Eda, S. Kondoh, K. Morimoto, T. Tanaka, E. Yamaguchi, A. Takahashi, M. Oda, H. Ishii, S. Izumi, H. Sugiyama, A. Nakagawa, K. Tomii, M. Suzuki, S. Konno, S. Ohkouchi, T. Hirano, T. Handa, T. Hirai, Y. Inoue, T. Arai, K. Asakawa, T. Sakagami, T. Tanaka, A. Mikami, N. Kitamura. Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kit. Erj Open Research. 2020 Jan;6(1):10.(井上義一)
• 65. M. Tamiya, A. Tamiya, H. Suzuki, Y. Taniguchi, K. Katayama, S. Minomo, K. Nakao, N. Takeuchi, Y. Matsuda, Y. Naito, T. Shiroyama, N. Okamoto, K. Okishio, T. Kumagai, S. Atagi, F. Imamura, T. Hirashima. Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion. Investigational New Drugs. 7.(田宮朗裕)

和文原著・著書等

• 1. 井上義一. 進行性線維化を伴う間質性肺疾患（PF-ILD）の概念とその管理. 呼吸器内科. 2021;39(3):171-177.
• 2. 増井伸高、倉原優ら. CASE7 呼吸器内科医にコンサルト. 救急現場から専門医へ あの先生にコンサルトしよう!. 2021;
• 3. 倉原優. 空間除菌は無意味どころか・・・. 日本医事新報. 2021;(5054):60.
• 4. 倉原優. 呼吸器感染症よもやま話.(25) . J-IDEO. 2021;5(2):260-261.
• 5. 倉原優. 新型コロナウイルス（SARS-CoV-2）ワクチンの副反応報道が始まった. 日本医事新報. 2021;(5050):70.
• 6. 松田能宣.  緩和治療薬. 呼吸器薬物療法-現場ではこう使いこなす. 呼吸器ジャーナル. 2021;69(1):p126-131.
• 7. 澄川裕充, 井上義一. 間質性肺炎の画像特徴. リウマチ科. 2021;65(1):44519.
• 8. 倉原優. SARS-CoV-2核酸ワクチンの期待と懸念. 日本医事新報. 2021;(5047):56-57.
• 9. 倉原優. 呼吸器感染症よもやま話.(24). J-IDEO. 2021;5(1):82-83.
• 10. 一和多俊男，内田寛治，石田学，赤坂 圭一，新井 徹，大河内眞也，富井 啓介，山口 悦郎，井上 義一，中田 光. 自己免疫性肺胞蛋白症に対する片側全肺洗浄法に関するワークショップサマリー. 日本呼吸器学会誌. 2021;10(1):44236.
• 11. 井上義一. 進行性線維化を伴う間質性肺疾患(PF-ILD)/進行性フェノタイプを示す慢性線維化性間質性肺疾患：新たな概念. 呼吸器内科. 2020;38(6):576-581.
• 12. 松田能宣.  かかりつけ医に必要な心療内科の知識 呼吸器・アレルギー心身症：喘息患者で使える心身医学的アプローチ. 日臨内科医会誌. 2020;35(4):p317-320.
• 13. 倉原優. 大阪府のコロナ第3波の現状. 日本医事新報. 2020;(5041):56.
• 14. 松田能宣. 心療内科医が実践する緩和ケア. Gノート. 2020;7(8):p1326-1331.
• 15. 松田能宣. 超実践的!だれでも使える心理療法のエッセンス(第4回) 交流分析を意識したコミュニケーション. 薬事. 2020;62(16):p1326-1331.
• 16. 井上義一. リンパ脈管筋腫症. 最新ガイドラインに基づく 呼吸器疾患 診療指針 2021-'22. 2020;415-421.
• 17. 倉原優. 肺結核の診断エラーはなぜ起こる？. 医学と薬学. 2020;77(4):473-476.
• 18. 倉原優. プレプリントの功罪. 日本医事新報. 2020;(5038):56.
• 19. 倉原優. インフルは咳から、COVID-19は熱から. 日経メディカル. 2020;1152-53.
• 20. 倉原優. 呼吸器感染症よもやま話.(23) . J-IDEO. 2020;4(6):954-956.
• 21. 吉田志緒美. 特集・非結核性抗酸菌症を考える：肺疾患を中心に 非結核性抗酸菌の主要薬剤の耐性機序. 呼吸器内科. 2020;38(5):464～474.
• 22. 松田能宣.  FAST FACT パニック発作・パニック症. 緩和ケア. 2020;30(6):p491.
• 23. 上西珠実、今長京子、土田麗央奈、佐々木達彦、玉舎学、吉田志緒美、樋口富士夫. 呼気一酸化窒素（FENO）測定の季節性変動について. 医学検査. 2020;69(4):534～538.
• 24. 松田能宣.  第2章. 3. 慢性閉塞性肺疾患（COPD）. 月刊薬事. 2020;62(14):p60-66.
• 25. 倉原優. 咳・痰.  総合診療. 2020;30(10):1191-1194.
• 26. 倉原優. SNSで広がるHPVワクチンのクラウドファンディング. 日本医事新報. 2020;(5033):64-65.
• 27. 井上義一. 治療最前線 抗線維化剤｢オフェブ｣. 薬事ニュース. 2020;14.
• 28. 久村正樹、倉原優ら. 気管支鏡. ERで闘うための手技. 2020;246-255.
• 29. 鈴木克洋. 特集「肺炎」肺結核と肺非結核性抗酸菌症. Medical Practice. 2020;37(10):1537-1540.
• 30. 井上義一, 西山理, 尾形誠. ご存知ですか？徳栄製肺線維症（ＩＰＦ）. 産経新聞 朝刊. 2020;20.
• 31. 松田能宣. 第3章. 5 非がんの呼吸器疾患で使える薬剤のバリエーションは？. 倉田宝保監修 蓮尾英明編集 がん治療医が本当に知りたかった緩和ケアのレシピ. 2020;p271-272.
• 32. 倉原優. 増えるマスク熱中症. 日本医事新報. 2020;(5029):61.
• 33. 倉原優. 呼吸器感染症よもやま話.(22). J-IDEO. 2020;4(5):794-795.
• 34. 松田能宣.  超実践的!だれでも使える心理療法のエッセンス(第1回) リフレーミング. 月刊薬事. 2020;62(12):p2393-2396.
• 35. 松田能宣. 実践施設に学ぶ！患者の「生きる」を支えるPCT当院の緩和ケアチーム活動の実践報告【第26回】呼吸器疾患専門病院としての緩和ケアチーム活動. エンド・オブ・ライフケア. 2020;4(4):p95-98.
• 36. 松田能宣.  肺がん患者の緩和ケアとアドバンス・ケア・プランニング. 日本呼吸ケア・リハビリテーション学会誌. 2020; 29巻(1号): Page75-77.
• 37. 倉原優. コロナ禍の最前線に立つ看護師の大量辞職. 日本医事新報. 2020;(5025):57.
• 38. 松田能宣 . 第2章 3) 不安と呼吸困難・不定愁訴. 小山敦子編集 がん診療における精神症状心理状態発達障害ハンドブック. 2020;p99-106.
• 39. 松田能宣. 総論. V治療. 24. 呼吸器疾患の緩和ケア. B. 非悪性腫瘍. 新 呼吸器専門医テキスト改訂第2版. 2020;p311-312.
• 40. 倉原優. 過剰な感染対策. 日本医事新報. 2020;(5020):59.
• 41. 倉原優. COVID-19（新型コロナウイルス感染症）のまん延期. コミュニティケア. 2020;22(8):25-28.
• 42. 倉原優. 呼吸器感染症よもやま話.(21). J-IDEO. 2020;4(4):668-669.
• 43. 倉原優. 書評「非がん患者の緩和ケア」. 薬事. 2020;62(9):74.
• 44. 吉田志緒美.  技術講座 微生物;抗酸菌検査 . 検査と技術. 2020;48(7):700～708.
• 45. 小山敦子, 所昭宏2 山田祐. 心身医学とサイコオンコロジーの未来戦略 ~心療内科医の立場から~ . 日本心療内科学会誌. 2020;24(2):５５－６２.
• 46. 佐々木由美子, 井上義一. 4 慢性好酸球性肺炎(CEP). 間質性肺疾患診療マニュアル（改訂第3版）. 2020;462-464.
• 47. 倉原優. 医療者へのCOVID-19差別. 日本医事新報. 2020;(5016):55.
• 48. 片山加奈子, 新井徹, 笠井孝彦, 審良正則, 井上義一. AL アミロイドーシス -自験例と文献的考察-. BIO Clinica. 2020;35(6):73-78.
• 49. 倉原優. 呼吸器内科領域の勘違いプラクティス. J-COSMO. 2020;2(3):420-421.
• 50. 川瀬啓祐、吉田志緒美、中郡翔太郎、古林与志安、椎原春一. 3種類の非結核性抗酸菌による肉芽腫病変が認められたボールニシキヘビ（Python regius）の全身播種性感染症の一例 . 日本野生動物医学会誌. 2020;25(1):35～40.
• 51. 倉原優. それほど専門家ではない専門家がテレビに出ている件. 日本医事新報. 2020;(5012):67.
• 52. 倉原優. 肺癌の分子標的薬の誕生. 総合診療. 2020;30(5):549-552.
• 53. 松本錦之介、小林岳彦、倉原優、嶋谷泰明、木原実香、吉田志緒美、露口一成、鈴木克洋、林清二. Mycobacterium kansasiiと結核菌の混合感染として治療を行なった後に多剤耐性結核を発症した１例 . 結核 . 2020;95(3):99～102.
• 54. 倉原優. なぜかHPVワクチンが接種されない先進国. 日本医事新報. 2020;(5010):63.
• 55. 倉原優. 呼吸器感染症よもやま話.(20). J-IDEO. 2020;4(3):394-395.
• 56. 岡田全司. 結核ワクチンの現状と展望（結核治療・予防ワクチンの治験を含む）. 呼吸器内科. 2020;37(5):512-519.
• 57. 井上義一. 抗線維化薬. 膠原病に伴う間質性肺疾患 診断・治療指針2020. 2020;190-195.
• 58. 井上義一. 進行性フェノタイプを示す慢性線維化性間質性肺疾患（進行性線維化を伴う間質性肺疾患）. 膠原病に伴う間質性肺疾患 診断・治療指針2020. 2020;146-150.
• 59. 井上義一. 進行性フェノタイプを示す慢性線維化性間質性肺疾患（進行性線維化を伴う間質性肺疾患）. 膠原病に伴う間質性肺疾患 診断・治療指針2020. 2020;190-195.
• 60. 倉原優. COVID-19による外勤禁止が招く医療崩壊. 日本医事新報. 2020;(5008):63.
• 61. 倉原優. Twitterで叫ばれる医師過労問題、つまるところお金の問題. 日本医事新報. 2020;(5006):64.
• 62. 倉原優. ポケット呼吸器診療2020. ポケット呼吸器診療2020. 2020;
• 63. 倉原優. 呼吸器内科のダメ処方. J-COSMO. 2020;2(2):209.
• 64. 倉原優. 新型コロナウイルス感染症を知るための11の論文. J-IDEO＋. 2020;442-57.
• 65. 倉原優. 早分かり診療ガイドライン. 慢性閉塞性肺疾患（COPD）. medicina. 2020;57(4):87-89.